Patent Grant
12016766
An aneurysm is a medical condition indicated generally by an expansion and weakening of the wall of an artery of a patient. Aneurysms can develop at various sites within a patient's body. Thoracic aortic aneurysms (TAAs) or abdominal aortic aneurysms (AAAs) are manifested by an expansion and weakening of the aorta which is a serious and life threatening condition for which intervention is generally indicated. Existing methods of treating aneurysms include invasive surgical procedures with graft replacement of the affected vessel or body lumen or reinforcement of the vessel with a graft.
Surgical procedures to treat aortic aneurysms can have relatively high morbidity and mortality rates due to the risk factors inherent to surgical repair of this disease as well as long hospital stays and painful recoveries. This is especially true for surgical repair of TAAs, which is generally regarded as involving higher risk and more difficulty when compared to surgical repair of AAAs. An example of a surgical procedure involving repair of a AAA is described in a book titled Surgical Treatment of Aortic Aneurysms by Denton A. Cooley, M.D., published in 1986 by W. B. Saunders Company.
Due to the inherent risks and complexities of surgical repair of aortic aneurysms, endovascular repair has become a widely-used alternative therapy, most notably in treating AAAs. Early work in this field is exemplified by Lawrence, Jr. et al. in “Percutaneous Endovascular Graft: Experimental Evaluation”, Radiology (May 1987) and by Mirich et al. in “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study,” Radiology (March 1989). Commercially available endoprostheses for the endovascular treatment of AAAs include the AneuRx® stent graft manufactured by Medtronic, Inc. of Minneapolis, MN, the Zenith® stent graft system sold by Cook, Inc. of Bloomington, IN, the PowerLink® stent-graft system manufactured by Endologix, Inc. of Irvine, CA, and the Excluder® stent graft system manufactured by W.L. Gore & Associates, Inc. of Newark, DE A commercially available stent graft for the treatment of TAAs is the TAG™ system manufactured by W.L. Gore & Associates, Inc.
When deploying devices by catheter or other suitable instrument, it is advantageous to have a flexible and low profile stent graft and delivery system for passage through the various guiding catheters as well as the patient's sometimes tortuous anatomy. Many of the existing endovascular devices and methods for treatment of aneurysms, while representing significant advancement over previous devices and methods, use systems having relatively large transverse profiles, often up to 24 French. Also, such existing systems have greater than desired lateral stiffness, which can complicate the delivery process. In addition, the sizing of stent grafts may be important to achieve a favorable clinical result. In order to properly size a stent graft, the treating facility typically must maintain a large and expensive inventory of stent grafts in order to accommodate the varied sizes of patient vessels due to varied patient sizes and vessel morphologies. Alternatively, intervention may be delayed while awaiting custom size stent grafts to be manufactured and sent to the treating facility. As such, minimally invasive endovascular treatment of aneurysms is not available for many patients that would benefit from such a procedure and can be more difficult to carry out for those patients for whom the procedure is indicated. What has been needed are stent graft systems and methods that are adaptable to a wide range of patient anatomies and that can be safely and reliably deployed using a flexible low profile system.
Some embodiments of a modular endovascular graft assembly include a bifurcated main graft member formed from a supple graft material having a main fluid flow lumen therein. The main graft member may also include an ipsilateral leg with an ipsilateral fluid flow lumen in communication with the main fluid flow lumen, a contralateral leg with a contralateral fluid flow lumen in communication with the main fluid flow lumen and a network of inflatable channels disposed on the main graft member. The network of inflatable channels may be disposed anywhere on the main graft member including the ipsilateral and contralateral legs. The network of inflatable channels may be configured to accept a hardenable fill or inflation material to provide structural rigidity to the main graft member when the network of inflatable channels is in an inflated state. The network of inflatable channels may also include at least one inflatable cuff disposed on a proximal portion of the main graft member which is configured to seal against an inside surface of a patient's vessel. The fill material can also have transient or chronic radiopacity to facilitate the placement of the modular limbs into the main graft member. A proximal anchor member may be disposed at a proximal end of the main graft member and be secured to the main graft member. The proximal anchor member may have a self-expanding proximal stent portion secured to a self-expanding distal stent portion with struts having a cross sectional area that is substantially the same as or greater than a cross sectional area of proximal stent portions or distal stent portions adjacent the strut. At least one ipsilateral graft extension having a fluid flow lumen disposed therein may be deployed with the fluid flow lumen of the graft extension sealed to and in fluid communication with the fluid flow lumen of the ipsilateral leg of the main graft member. At least one contralateral graft extension having a fluid flow lumen disposed therein may be deployed with the fluid flow lumen of the graft extension sealed to and in fluid communication with the fluid flow lumen of the contralateral leg of the main graft member. For some embodiments, an outside surface of the graft extension may be sealed to an inside surface of the contralateral leg of the main graft when the graft extension is in a deployed state. For some embodiments, the axial length of the ipsilateral and contralateral legs may be sufficient to provide adequate surface area contact with outer surfaces of graft extensions to provide sufficient friction to hold the graft extensions in place. For some embodiments, the ipsilateral and contralateral legs may have an axial length of at least about 2 cm. For some embodiments, the ipsilateral and contralateral legs may have an axial length of about 2 cm to about 6 cm, more specifically, about 3 cm to about 5 cm.
Some embodiments of a modular endovascular graft assembly include a bifurcated main graft member having an axial length of about 5 cm to about 10 cm formed from a supple graft material. The main graft member has a main fluid flow lumen therein, an ipsilateral leg with an ipsilateral fluid flow lumen in communication with the main fluid flow lumen and with an axial length of at least about 2 cm, a contralateral leg with a contralateral fluid flow lumen in communication with the main fluid flow lumen and with an axial length of at least about 2 cm. The main graft member also includes network of inflatable channels disposed on the main graft member, including the ipsilateral and contralateral legs, which is configured to accept a hardenable fill material to provide structural rigidity to the main graft member when the network of inflatable channels are in an inflated state. The network of inflatable channels may also include at least one inflatable cuff disposed on a proximal portion of the main graft member configured to seal against an inside surface of a patient's vessel. A proximal anchor member may be disposed at a proximal end of the main graft member and secured to the main graft member. The proximal anchor member may have a self-expanding proximal stent portion secured to a self-expanding distal stent portion with struts. At least one ipsilateral graft extension having a fluid flow lumen disposed therein may have the fluid flow lumen of the graft extension sealed to and in fluid communication with the fluid flow lumen of the ipsilateral leg of the main graft member. At least one contralateral graft extension having a fluid flow lumen disposed therein may have the fluid flow lumen of the graft extension sealed to and in fluid communication with the fluid flow lumen of the contralateral leg of the main graft member.
Some embodiments of a method of treating a patient include providing a delivery catheter containing a radially constrained bifurcated main graft member. The main graft member may be formed from a supple graft material which has a main fluid flow lumen therein and which has an ipsilateral leg with an ipsilateral fluid flow lumen in communication with the main fluid flow lumen and a contralateral leg with a contralateral fluid flow lumen in communication with the main fluid flow lumen. The main graft member may also include a network of inflatable channels disposed on the main graft member. Inflatable channels of the network of inflatable channels may be disposed on any portion of the main graft member including the ipsilateral and contralateral legs of the main graft member. The main graft member may also include a proximal anchor member which is disposed at a proximal end of the main graft member and secured to the main graft member. The proximal anchor member may have a self-expanding proximal stent portion secured to a self-expanding distal stent portion. Such a delivery catheter may be axially positioned within the patient's vasculature such that the main graft member within the delivery catheter is disposed coextensively with a vascular defect of the patient's aorta. Once this positioning has been achieved, the proximal anchor member may be deployed so as to radially expand and engage an inner surface of the patient's vasculature and anchor the proximal anchor member to the patient's aorta. Thereafter, the network of inflatable channels of the main graft member may be inflated with an inflation material so as to provide a more mechanically rigid structure of the main graft member. For some embodiments, inflation of the network of inflatable channels may also provide a seal between an outer surface of an inflatable cuff of the main graft member and an inside surface of the patient's body lumen in contact with the inflatable cuff. For some embodiments, a hardenable fill material may be used that may assume or more solid configuration after inflation of the network of inflatable channels so as to provide additional mechanical rigidity as well as prevent leakage of the fill material. Some embodiments may also employ radiopaque inflation material to facilitate monitoring of the fill process and subsequent engagement of graft extensions. A second delivery catheter containing a radially constrained self-expanding contralateral graft extension may then be axially positioned in the contralateral leg of the main graft member with a proximal portion of the contralateral graft extension axially overlapped with an inner fluid flow lumen of the contralateral leg of the main graft member and a distal portion of the contralateral graft extension axially overlapped with a portion of the patient's contralateral iliac artery. Access to the contralateral leg of the main graft portion may be achieved by percutaneous access or femoral arteriotomy from the patient's contralateral femoral artery with a delivery sheath or the like. Once properly positioned, the self-expanding contralateral graft extension may be deployed by releasing the radial constraint of the second delivery catheter. As the contralateral graft extension self expands in an outward radial orientation, a seal between the inner fluid flow lumen of the contralateral graft extension, a fluid flow lumen of the contralateral leg and a fluid flow lumen of the contralateral iliac artery may be formed. A third delivery catheter containing a radially constrained self-expanding ipsilateral graft extension may also be axially positioned in the ipsilateral leg of the main graft member with a proximal portion of the ipsilateral graft extension axially overlapped with an inner fluid flow lumen of the ipsilateral leg of the main graft member and a distal portion of the ipsilateral graft extension axially overlapped with a portion of the patient's ipsilateral iliac artery. The self-expanding ipsilateral graft extension may then be deployed by releasing the radial constraint so as to form a seal between the inner fluid flow lumen of the ipsilateral graft extension, a fluid flow lumen of the ipsilateral leg and a fluid flow lumen of the ipsilateral iliac artery. The ipsilateral and contralateral graft extensions may be delivered and deployed in either order.
Some embodiments of a graft extension include a fluid flow lumen disposed therein, at least one layer of permeable PTFE material, at least one layer of semi-permeable or substantially non-permeable PTFE material having no discernable node and fibril structure and an interposed self-expanding stent formed from an elongate resilient element helically wound with a plurality of longitudinally spaced turns into an open tubular configuration disposed between at least one outer layer and at least one inner layer of PTFE material.
These features of embodiments will become more apparent from the following detailed description when taken in conjunction with the accompanying exemplary drawings.
Embodiments of the invention are directed generally to methods and devices for treatment of fluid flow vessels with the body of a patient. Treatment of blood vessels is specifically indicated for some embodiments, and, more specifically, treatment of aneurysms, such as abdominal aortic aneurysms.
Some embodiments of a modular endovascular graft assembly may include a bifurcated main graft member formed from a supple graft material, such as ePTFE, having a main fluid flow lumen therein. The main graft member may also include an ipsilateral leg with an ipsilateral fluid flow lumen in communication with the main fluid flow lumen, a contralateral leg with a contralateral fluid flow lumen in communication with the main fluid flow lumen and a network of inflatable channels disposed on the main graft member. For some embodiments, the main graft member may have an axial length of about 5 cm to about 10 cm, more specifically, about 6 cm to about 8 cm in order to span an aneurysm of a patient's aorta without engaging the patient's iliac arteries directly with the legs of the main graft member.
The inflatable channels of the network of inflatable channels may be disposed on any portion of the main graft member including the ipsilateral and contralateral legs. The network of inflatable channels may be configured to accept a hardenable fill material to provide structural rigidity to the main graft member when the network of inflatable channels are in an inflated state and the inflation material has been cured or hardened. Radiopaque inflation material may be used to facilitate monitoring of the fill process and subsequent engagement of graft extensions. The network of inflatable channels may also include at least one inflatable cuff disposed on a proximal portion of the main graft member which is configured to seal against an inside surface of a patient's vessel, such as the aorta.
A proximal anchor member is disposed at a proximal end of the main graft member and secured to the main graft member. The proximal anchor member has a self-expanding proximal stent portion secured to a self-expanding distal stent portion with struts. Some embodiments of the struts may have a cross sectional area that is substantially the same as or greater than a cross sectional area of proximal stent portions or distal stent portions adjacent the strut. Such a configuration may be useful in avoiding points of concentrated stress in the proximal anchor member or struts which couple components thereof. For some embodiments, the proximal stent of the proximal anchor member further includes a plurality of barbs having sharp tissue engaging tips that are configured to extend in a radial outward direction in a deployed expanded state. For some embodiments, the proximal anchor member includes a 4 crown proximal stent portion and a 8 crown distal stent portion which may be made from a superelastic alloy such as superelastic NiTi alloy.
At least one ipsilateral graft extension having a fluid flow lumen disposed therein may be deployed with the fluid flow lumen of the graft extension sealed to and in fluid communication with the fluid flow lumen of the ipsilateral leg of the main graft member. In addition, at least one contralateral graft extension having a fluid flow lumen disposed therein may be deployed with the fluid flow lumen of the graft extension sealed to and in fluid communication with the fluid flow lumen of the contralateral leg of the main graft member. For some embodiments, the graft extensions may include an interposed self-expanding stent disposed between at least one outer layer and at least one inner layer of supple layers of graft material. The interposed stent disposed between the outer layer and inner layer of graft material may be formed from an elongate resilient element helically wound with a plurality of longitudinally spaced turns into an open tubular configuration. For some embodiments, the interposed stent is may include a superelastic alloy such as superelastic NiTi alloy. In addition, the graft material of each graft extension may further include at least one axial zone of low permeability for some embodiments.
For some embodiments, an outside surface of the graft extension may be sealed to an inside surface of the contralateral leg of the main graft when the graft extension is in a deployed state. For some embodiments, the axial length of the ipsilateral and contralateral legs may be sufficient to provide adequate surface area contact with outer surfaces of graft extensions to provide sufficient friction to hold the graft extensions in place. For some embodiments, the ipsilateral and contralateral legs may have an axial length of at least about 2 cm. For some embodiments, the ipsilateral and contralateral legs may have an axial length of about 2 cm to about 6 cm, more specifically, about 3 cm to about 5 cm.
The main fluid flow lumen 18 (shown in
With regard to graft embodiments discussed herein, such as graft assembly 10, and components thereof, as well as graft extensions 14 and 15, the term “proximal” refers to a location towards a patient's heart and the term “distal” refers to a location away from the patient's heart. With regard to delivery system catheters and components thereof discussed herein, the term “distal” refers to a location that is disposed away from an operator who is using the catheter and the term “proximal” refers to a location towards the operator.
The ipsilateral graft extension 14 has a fluid flow lumen 44 disposed therein. The ipsilateral graft extension 14 has an outer surface which may be sized and configured to be sealed to an inside surface of the ipsilateral leg of the main graft with the inner fluid flow lumen 44 of the ipsilateral graft extension 14 in fluid communication with the fluid flow lumen 24 of the ipsilateral leg 20. Typically, an outside surface 46 of the graft extension 14 may be sealed to an inside surface 48 of the ipsilateral leg 20 of the main graft 12 when the graft extension 14 is in a deployed state. The contralateral graft extension 15 has a fluid flow lumen 45 disposed therein. The contralateral graft extension 15 has an outer surface 47 which may be sized and configured to be sealed to an inside surface 50 of the contralateral leg 26 of the main graft 12 with the inner fluid flow lumen 45 in fluid communication with the fluid flow lumen 30 of the contralateral leg 26. Typically, an outside surface 47 of the graft extension 15 may be sealed to an inside surface 50 of the contralateral leg 26 of the main graft 12 when the graft extension 15 is in a deployed state. For some embodiments, the axial length of the ipsilateral and contralateral legs 20 and 26 may be sufficient to provide adequate surface area contact between outer surfaces 46 and 47 of graft extensions 14 and 15 and respective inside surfaces 48 and 50 of the legs 20 and 26 to provide sufficient friction to hold the graft extensions 14 and 15 in place. Varying the amount of overlap between the legs and extensions can allow for different effective overall graft lengths to be achieved, thereby accommodating a range of anatomical sizes with fewer distinct main body and extension dimensions than would otherwise be required. For some embodiments, the ipsilateral and contralateral legs 20 and 26 may have an axial length of at least about 1 cm. For some embodiments, the ipsilateral and contralateral legs 20 and 26 may have an axial length of about 2 cm to about 6 cm, more specifically, about 3 cm to about 5 cm.
The graft extensions 14 and 15 may be formed from an inner layer or layers and outer layer or layers of flexible graft material, such as PTFE or ePTFE. The inner and outer layers of graft material may be formed from tubular extrusions, laminated wraps of multiple layers of graft material or materials, and the like. The inner or outer layers of graft material may be permeable, semi-permeable or substantially non-permeable for some embodiments. For some embodiments, the nominal length of the extensions 14 and 15 may be permeable with one or more longitudinal sections, such as a middle longitudinal section, being semi-permeable or non-permeable. Some embodiments of the graft extensions 14 and 15 may have an overall tapered or flared configuration with a nominal inner lumen that tapers or flares when the graft extension is in a relaxed expanded state. For embodiments that include laminated wraps of material, the wraps may be carried out circumferentially, helically or in any other suitable configuration.
A radially expandable stent 51 may be interposed between the outer layer 54 and inner layer 56 of graft material of extensions 14 and 15. The interposed stent disposed between the outer layer and inner layer of graft material may be formed from an elongate resilient element helically wound with a plurality of longitudinally spaced turns into an open tubular configuration. The helically wound stent 51 may be configured to be a self-expanding stent or radially expandable in an inelastic manner actuated by an outward radial force from a device such as an expandable balloon or the like. Some tubular prosthesis embodiments that may be used for graft extensions 14 and 15 are discussed in U.S. Pat. No. 6,673,103 to Golds et al., filed May 16, 2000 titled “Mesh and Stent for Increased Flexibility”, which is hereby incorporated by reference in its entirety herein.
The graft extensions 14 and 15 may optionally include attachment elements disposed on outer surfaces 46 and 47 (shown in
The transverse dimension or diameter of the main fluid flow lumen 18 of some main graft embodiments 12 in a radially expanded state may be from about 12.0 mm to about 32.0 mm. The transverse dimension or diameter of the ipsilateral and contralateral fluid flow lumens 24 and 30 of the respective ipsilateral leg 20 and contralateral leg 26 may be from about 5 mm to about 20 mm for some embodiments. The axial length of the contralateral leg 26 is indicated by arrow 57 in
The main graft 12 and ipsilateral graft extensions 14 and 15 may be made at least partially from polytetrafluoroethylene (PTFE) which may include expanded polytetrafluoroethylene (ePTFE). In particular, main graft 12 and graft extensions 14 and 15 may include any number of layers of PTFE and/or ePTFE, including from about 2 to about 15 layers, having an uncompressed layered thickness of about 0.003 inch to about 0.015 inch for the supple graft material or materials alone without supporting or ancillary structures such as high strength stents, connector rings or the like. Unless otherwise specifically stated, the term “PTFE” as used herein includes PTFE, porous PTFE and ePTFE, any of which may be impermeable, semi-permeable, or permeable. Furthermore, the graft assembly and any portions thereof including the main body and extensions described herein may include all PTFE, all ePTFE, or a combination thereof. Such graft body sections may also include any alternative high strength, supple biocompatible materials, such as DACRON, suitable for graft applications. Descriptions of various constructions of graft body sections as well as other components of graft assembly 10 that may be used in any suitable combination for any of the embodiments discussed herein may be found in U.S. patent application Ser. No. 10/029,557, publication US 2003/0116260 A1, filed Dec. 20, 2001 by Chobotov, et al., entitled “Method and Apparatus for Manufacturing an Endovascular Graft Section”, U.S. patent application Ser. No. 10/029,584, filed Dec. 20, 2001 by Chobotov et al., entitled “Endovascular Graft Joint and Method of Manufacture”, U.S. patent application Ser. No. 10/029,559, entitled “Method and Apparatus for Shape Forming Endovascular Graft Material”, filed on Dec. 20, 2001 by Chobotov et al., U.S. Pat. No. 7,147,660, filed Dec. 20, 2002, by Chobotov et al., entitled “Advanced Endovascular Graft”, U.S. patent application Ser. No. 11/106,131, publication US 2006/0233990A1, filed Apr. 13, 2005, by Humphrey et al. entitled “PTFE Layers and Methods of Manufacturing”, and U.S. patent application Ser. No. 11/106,150, publication US 2006/0233991, filed Apr. 13, 2005, by Humphrey et al., entitled “PTFE Layers and Methods of Manufacturing”, the entirety of each of which is incorporated herein by reference.
The laminated structure of various portions of the graft member 12, including ipsilateral and contralateral legs 20 and 26, extensions 14 and 15, or all of these, may include a variety of configurations wherein laminate materials having similar but different properties may be used together or individually. For example, some embodiments of a main body portion of the graft member 12 may have a laminated structure of about 1 layer to about 5 layers of porous ePTFE material having a mean nodal spacing of about 5 microns to about 35 microns, more specifically, about 10 microns to about 25 microns, and a thickness of about 0.0002 inches to about 0.002 inches, more specifically, about 0.0005 inches to about 0.0015 inches. The main body portion of the graft member 12 may also include about 1 layer to about 5 layers of semi-permeable PTFE having a first permeability and a thickness of about 0.0002 inches to about 0.002 inches, more specifically, about 0.0004 inches to about 0.001 inches. The main body portion may also include about 1 layer to about 5 layers of semi-permeable PTFE material having a second permeability different from the first permeability and a thickness of about 0.0002 inches to about 0.002 inches, more specifically, about 0.0004 inches to about 0.001 inches. Any suitable embodiments of the semi-permeable layers of PTFE discussed in U.S. Patent Applications 2006/0233990 and 2006/0233991, incorporated by reference above, may be used in these embodiments. The main body portion may also include about 1 layer to about 5 layers of PTFE having essentially no nodal spacing and very low or no liquid permeability and a thickness of about 0.0001 inches to about 0.0015 inches, more specifically, about 0.0002 inches to about 0.001 inches.
For embodiments of modular graft systems that do not include the attachment elements, outside surfaces 46 and 47 of the proximal ends of the graft extensions 14 and 15 may be expanded against the inside surfaces 48 and 50, respectively, of the fluid flow lumens of legs 20 and 26 of the graft member 12. This configuration may be used to seal the fluid flow lumens 44 and 45 of the graft extensions 14 and 15 to the fluid flow lumens 24 and 30 of the legs 20 and 26. Expandable members, such as expandable anchor members and the like, may be used to expand the graft extensions 14 and 15 against the inside surfaces 48 and 50 of the fluid flow lumens 24 and 30 of the legs 20 and 26.
A network of inflatable elements or channels 58 is disposed on the main graft 12 which may be inflated under pressure with an inflation material (not shown) through a main fill port 60 that has a lumen disposed therein in fluid communication with the network of inflatable channels 58. The inflation material may be retained within the network of inflatable channels 58 by a one way-valve (not shown), disposed within the lumen of the main fill port 60. The network of inflatable channels 58 may optionally be filled with a hardenable material that may be configured to harden, cure or otherwise increase in viscosity or become more rigid after being injected into the channels. Hardenable inflation materials such as gels, liquids or other flowable materials that are curable to a more solid or substantially hardened state may be used to provide mechanical support to the main graft 12 and legs by virtue of the mechanical properties of the hardened material disposed within the channels. The network of inflatable channels 58 may also provide structural support to the main graft 12 when in an inflated state due to the stiffness of the channels created by the increased interior pressure within the channels even if a non-hardenable inflation material, such as saline or the like, is used so long as an increased interior pressure can be maintained. Such an increase in stiffness or rigidity may be useful for a variety of purposes. For example, during deployment, inflation of the network of inflatable channels may urge the main graft body including the main flow channel and legs thereof to conform to a generally cylindrical configuration having open flow lumens which may be useful when attempting to locate and navigate the flow lumens of the contralateral or ipsilateral leg with a delivery catheter, guidewire or the like. Such location and navigation of the flow lumens of the main graft body and portions thereof may also be facilitated by the use of radiopaque inflation materials that provide enhanced visualization under fluoroscopic imaging.
The network of inflatable channels 58 may include one or more circumferential channels disposed completely or partially about the main graft or legs of the main graft as well as longitudinal or helical channels that may provide support as well as a conduit in communication with the circumferential channels that may be used for filling the network of inflatable channels with inflation material. Some embodiments may also employ radiopaque inflation material to facilitate monitoring of the fill process and subsequent engagement of graft extensions. The network of inflatable channels 58 may also include one or more one or more enlarged circumferential channels in the form of inflatable cuffs, such as proximal inflatable cuff 62, which may be configured to seal to an inside surface of a patient's vessel such as a patient's abdominal aorta. Proximal inflatable cuff 62 is disposed on a proximal portion of the main graft 12 distal of the proximal anchor member 32 and has an outer surface that extends radially from a nominal outer surface of the main graft 12. The inflatable cuff 62 may be configured to expand radially beyond a nominal outer surface of the main graft 12 and provide a seal against an inside surface of a body lumen when the inflatable cuff 62 is inflated with an inflation material to an expanded state. The axial separation of the proximal anchor member 32 and proximal inflatable cuff 62 allows for spatial separation of the primary anchoring mechanism and at least part of the sealing function which may allow the graft to be restrained or otherwise compressed to a smaller outer profile for deployment from a delivery catheter. An interior cavity of the inflatable cuff 62 is in fluid communication with the interior cavity of the remaining network of inflatable channels and may have a transverse dimension or inner diameter of about 0.040 inch to about 0.250 inch.
Some embodiments of main graft member 12 may include about 1 to about 8 circumferential inflatable channels disposed about each leg 20 and 26 and about 1 to about 8 circumferential channels disposed about a main body portion of the main graft member 12. Some embodiments of the main graft body member 12 may include about 1 to about 4 longitudinal or axial inflatable channels that may serve to connect the circumferential inflatable channels. Some embodiments of the circumferential channels may extend a full circumference of the graft section upon which they are disposed, or they may extend only partially around the graft section upon which they are disposed. For the main graft member embodiment 12 shown in
Some of the inflatable channels of the graft member embodiments discussed herein may be disposed circumferentially and axially such as shown in the embodiment of
The inflatable cuff 62 and other network of inflatable channels 58 may be filled during deployment of the graft with any suitable inflation material. As discussed above, the inflation material may be used to provide outward pressure or a rigid structure from within the inflatable cuff 62 or network of inflatable channels 58. Biocompatible gases, liquids, gels or the like may be used, including curable polymeric materials or gels, such as the polymeric biomaterials described in pending U.S. patent application Ser. No. 09/496,231 filed Feb. 1, 2000, and entitled “Biomaterials Formed by Nucleophilic Addition Reaction to Conjugated Unsaturated Groups” to Hubbell el al. and pending U.S. patent application Ser. No. 09/586,937, filed Jun. 2, 2000, and entitled “Conjugate Addition Reactions for Controlled Delivery of Pharmaceutically Active Compounds” to Hubbell et al. and further discussed in commonly owned pending U.S. patent application Ser. No. 10/327,711, filed Dec. 20, 2002, and entitled “Advanced Endovascular Graft” to Chobotov, et al., each of which is incorporated by reference herein in its entirety. Some embodiments may use inflation materials formed from glycidyl ether and amine materials, as discussed in U.S. patent application Ser. No. 11/097,467, publication number 2006/0222596, filed Apr. 1, 2005, and entitled “Non-Degradable, Low-Swelling, Water Soluble Radiopaque Hydrogel Polymer” to Askari and Whirley. Some inflation material embodiments may include an in situ formed hydrogel polymer having a first amount of diamine and a second amount of polyglycidyl ether wherein each of the amounts are present in a mammal or in a medical device, such as an inflatable graft, located in a mammal in an amount to produce an in situ formed hydrogel polymer that is biocompatible and has a cure time after mixing of about 10 seconds to about 30 minutes and wherein the volume of said hydrogel polymer swells less than 30 percent after curing and hydration. Some embodiments of the inflation material may include radiopaque material such as sodium iodide, potassium iodide, barium sulfate, Visipaque 320, Hypaque, Omnipaque 350, Hexabrix and the like. For some inflation material embodiments, the polyglycidyl ether may be selected from trimethylolpropane triglycidyl ether, sorbitol polyglycidyl ether, polyglycerol polyglycidyl ether, pentaerythritol polyglycidyl ether, diglycerol polyglycidyl ether, glycerol polyglycidyl ether, trimethylolpropane polyglycidyl ether, polyethylene glycol diglycidyl ether, resorcinol diglycidyl ether, glycidyl ester ether of p-hydroxy benzoic acid, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, bisphenol A (PO)2 diglycidyl ether, hydroquinone diglycidyl ether, bisphenol S diglycidyl ether, terephthalic acid diglycidyl ester, and mixtures thereof. For some inflation material embodiments, the diamine may be selected from (poly)alkylene glycol having amino or alkylamino termini selected from the group consisting of polyethylene glycol (400) diamine, di-(3-aminopropyl) diethylene glycol r, polyoxypropylenediamine, polyetherdiamine, polyoxyethylenediamine, triethyleneglycol diamine and mixtures thereof. For some embodiments, the diamine may be hydrophilic and the polyglycidyl ether may be hydrophilic prior to curing. For some embodiments, the diamine may be hydrophilic and the polyglycidyl ether is hydrophobic prior to curing. For some embodiments, the diamine may be hydrophobic and the polyglycidyl ether may be hydrophilic prior to curing.
Other inflation materials that may be used for some embodiments include polyethylene oxide materials and neopentyl glycol diacrylate materials which are discussed in U.S. Pat. Nos. 6,610,035 and 6,176,849, which are incorporated by reference herein in their entirety. U.S. Pat. No. 7,147,660 discussed above also includes inflation material embodiments that may be used for embodiments discussed herein.
Referring to
The proximal anchor member 32 is secured to the connector ring 68 with flanged connector elements 70 as shown in
Referring again to
A similar structural configuration may be used at the junction between the connector ring 68 and the distal end of the distal stent 32B. For this junction, the struts 72 disposed between the connector ring 68 and connector elements 70, as shown in
The proximal anchor member 32 and components thereof may have a variety of configurations which may be collapsible to a small transverse dimension or diameter for percutaneous or other types of delivery and be expandable to engage the inside surface of the patient's vasculature to provide anchoring to the vasculature and prevent or oppose axial movement of the anchor member or the graft section attached thereto. Anchor member embodiments 32 may be configured as a self-expanding anchor member having an undulating pattern and may be made from stainless steel, nickel titanium alloy or any other suitable material. The anchor member 32 may be configured to be balloon expandable or self-expanding in an outward radial direction from a radially compressed state. The distal anchor member 32 and connector ring 68 may be formed by cutting the configuration of these elements from a single tubular piece of a selected material, such as the materials discussed above. The proximal stent 32A of the anchor member 32 may also optionally include barbs 33 that are angled outwardly from the anchor members and are configured to engage tissue of the vessel wall and prevent axial movement of the anchor members once deployed. The proximal anchor member 32 and proximal and distal stents 32A and 32B thereof may have the same or similar features, dimensions or materials to those of the stents described in U.S. patent application Ser. No. 10/327,711, US 2003/0125797 A1, filed Dec. 20, 2002, by Chobotov et al. which is hereby incorporated by reference in its entirety. The distal stent 32B of anchor member 32 may also be secured to connector ring 68 in the same or similar fashion as described in the incorporated application above.
It may be useful for some embodiments of the main graft 12 to have a nominal axial length which is configured to allow the use of the main graft 12 in a wide variety of vascular morphologies with supplementation by one or more graft extensions 14 and 15. A modular graft embodiment 10 is normally chosen in order to have a proper fit to the patient's vasculature. For some graft indications, it is necessary to produce a large number of size variations of the graft system, or graft assembly 10 components, in order to accommodate the size and configuration variations of each patient's vasculature in order to achieve an acceptable fit of the graft assembly 10 within the patient's vasculature. This can be very costly and time consuming for the manufacturer of the endovascular graft assembly 10 and the hospitals which must maintain a comprehensive inventory of the devices. In addition, this may require an inconvenient amount of shelf space in the hospital operating room or catheter lab. For some embodiments, main graft member 12 may have an axial length that is selected to allow anchoring of the proximal anchor member 32 adjacent the renal arteries extending from a patient's aorta with the legs of the bifurcated portion remaining clear of the iliac arteries in a large cross section of patients having diverse physical size and vascular configurations. In this way, the need for customizing a graft assembly 10 for a particular patient or group of patients can be avoided.
For some embodiments, the axial length of the main graft member 12, and particularly the axial distance or separation between the proximal anchor member 32 and distal end of the ipsilateral and contralateral legs 20 and 26 may be selected to extend across an abdominal aortic aneurysm without extending into the iliac arteries of a selected patient. A selected patient may be a member of a group of patients who has the longest axial separation between the sealing point in the aorta just distal to the renal arteries and a distal most viable anchor and sealing point in the iliac arteries. In some embodiments for a particular patient group, the proximal end of the main graft member 12 is axially separated from the distal ends of the ipsilateral and contralateral legs 20 and 26 by a length of about 5 cm to about 10 cm, more specifically, about 6 cm to about 8 cm, as indicated by the arrow 74 in
For some embodiments of sizing a main graft member embodiment 12, the separation of the proximal anchor member 32 and distal end of deployed graft extensions 14 and 15 is selected such that the separation is just long enough to span the separation between the renal arteries and the proximal most anchor and sealing point in the iliac artery or arteries of a patient. This distance may be determined from the patient, in a selected group of patients, that has the longest such separation in the selected group of patients. In addition, for these embodiments, this separation must be shorter than the separation between the renal arteries and hypogastric artery or arteries. The distance may be determined from the patient, in the selected group of patients, that has the shortest such separation in the selected group of patients. In this way, it may be possible to treat all members of a selected group of patients with a main graft member 12 embodiment or embodiments which have a common main graft body length. Such embodiments may be anchored to the patient's aorta distal of the patient's renal arteries and anchored distally in the patient's iliac artery or arteries, without blocking either the renal arteries or hypogastric artery or arteries. Such a modular graft system embodiment 10 may have an overall length including the main graft member 12 and deployed graft extensions 14 and 15 of about 10 cm to about 22 cm, specifically, about 11 cm to about 20 cm.
The careful sizing and configuring of the main graft 12 allows the use of a single main graft 12 embodiment or design to be adaptable to a wide range of patients when supplemented by one or more graft extensions 14 and 15. More specifically, a main graft 12 having an axial length of about 5 cm to about 8 cm may be properly deployed in a large percentage of potential patients. Once deployed, the fluid flow lumens 24 and 30 of the ipsilateral and contralateral legs 20 and 26 of the main graft 12 can then be sealed to the patient's iliac arteries with the deployment of graft extensions 14 and 15. Although the graft assembly 10 includes the option of using attachment elements to secure the graft extensions 14 and 15 to the ipsilateral leg and contralateral leg of the main graft 12, this may not be necessary in most cases and an adequate seal and mechanical fixation of a graft extensions 14 and 15 may be achieved with the use of a standard expandable member on the graft extensions 14 and 15 instead of an attachment element.
Some embodiments of a method of treating a patient include providing a delivery catheter containing a radially constrained bifurcated main graft member. The main graft member may be formed from a supple graft material which has a main fluid flow lumen therein and which has an ipsilateral leg with an ipsilateral fluid flow lumen in communication with the main fluid flow lumen and a contralateral leg with a contralateral fluid flow lumen in communication with the main fluid flow lumen. The main graft member may also include a network of inflatable channels disposed on the main graft member. Inflatable channels of the network of inflatable channels may be disposed on any portion of the main graft member including the ipsilateral and contralateral legs of the main graft member. The main graft member may also include a proximal anchor member which is disposed at a proximal end of the main graft member and secured to the main graft member. The proximal anchor member may have a self-expanding proximal stent portion secured to a self-expanding distal stent portion.
Such a delivery catheter may be axially positioned within the patient's vasculature such that the main graft member within the delivery catheter is disposed coextensively with a vascular defect of the patient's aorta. Once this positioning has been achieved, the proximal anchor member may be deployed so as to engage an inner surface of the patient's vasculature and anchor the proximal anchor member to the patient's aorta. Thereafter, the network of inflatable channels of the main graft member may be inflated with an inflation material so as to provide a more mechanically rigid structure. For some embodiments, a curable or hardenable fill material may be used that may be cured after inflation of the network of inflatable channels so as to provide additional mechanical rigidity as well as prevent leakage of the fill material. Some embodiments may also employ radiopaque inflation material to facilitate monitoring of the fill process and subsequent engagement of graft extensions.
A second delivery catheter containing a radially constrained self-expanding contralateral graft extension may then be axially positioned in the contralateral leg of the main graft member with a proximal portion of the contralateral graft extension axially overlapped with an inner fluid flow lumen of the contralateral leg of the main graft member and a distal portion of the contralateral graft extension axially overlapped with a portion of the patient's contralateral iliac artery. Access to the contralateral leg of the main graft portion may be achieved by percutaneous access or femoral arteriotomy from the patient's contralateral femoral artery with a delivery sheath or the like. Once properly positioned, the self-expanding contralateral graft extension may be deployed by releasing the radial constraint of the second delivery catheter. As the contralateral graft extension self expands in an outward radial orientation, a seal between the inner fluid flow lumen of the contralateral graft extension, a fluid flow lumen of the contralateral leg and a fluid flow lumen of the contralateral iliac artery may be formed.
A third delivery catheter containing a radially constrained self-expanding ipsilateral graft extension may then be axially positioned in the ipsilateral leg of the main graft member with a proximal portion of the ipsilateral graft extension axially overlapped with an inner fluid flow lumen of the ipsilateral leg of the main graft member and a distal portion of the ipsilateral graft extension axially overlapped with a portion of the patient's ipsilateral iliac artery. The self-expanding ipsilateral graft extension may then be deployed by releasing the radial constraint so as to form a seal between the inner fluid flow lumen of the ipsilateral graft extension, a fluid flow lumen of the ipsilateral leg and a fluid flow lumen of the ipsilateral iliac artery.
For some method embodiments of treating the vasculature of a patient, a modular graft assembly, such as the modular graft assembly embodiments 10 discussed above, may be used.
Once the delivery sheath or sheaths have been properly positioned, a delivery catheter 75 containing a modular graft assembly component, such as graft member 12, may then be advanced over a guidewire 76 through the delivery sheath and into the patient's vasculature. In one specific deployment method embodiment, the main graft member 12 is advanced within a delivery catheter 75 through the patient's vessel, typically in a proximal direction from the ipsilateral iliac artery, to a desired site of deployment, such as the abdominal aorta, in a constrained state via a catheter or like device having a low profile and lateral flexibility for ease of delivery through the patient's vasculature. At the desired site of deployment, the proximal anchor member 32 of the main graft 12 is released from a constrained state and the proximal anchor member 32 is allowed to expand and secure a portion of the main graft 12 to the patient's vasculature. Deployment of the modular graft assembly 10 may be carried out by any suitable devices and methods, including techniques and accompanying apparatus as disclosed in U.S. Pat. No. 6,761,733, entitled “Delivery Systems and Methods for Bifurcated Endovascular Graft” to Chobotov et al., filed on Jul. 27, 2001, and U.S. patent application Ser. No. 11/205,793, entitled “Delivery System and Method for Bifurcated Graft” to Chobotov et al., filed Aug. 15, 2005, which are incorporated by reference herein in their entirety.
The delivery catheter 75 may be advanced proximally upstream of blood flow, as indicated by arrows 77, into the vasculature of the patient including the iliac artery 78 and aorta 79 shown in
Deployment of the proximal anchor member 32 may begin with deployment of the distal stent 32B by retracting the wire or rod 86 that couples ends of belt 88 restraining distal stent 32B. Additional axial positioning may typically be carried out even after deploying the distal stent 32B of the proximal anchor member 32. This may still be carried out in many circumstances as the distal stent portion 32B of the distal anchor 32 does not include tissue engaging barbs 33 for some embodiments and will provide only partial outward radial contact or frictional force on the inner lumen of the patient's vessel 79 until the proximal stent 32A is deployed. Once the belt 86 constraining the distal stent 32B has been released, the distal stent 32B self-expands in an outward radial direction until an outside surface of the proximal stent 32B makes contact with and engages an inner surface 90 of the patient's vessel 79 as shown in
After the distal stent 32B has been deployed, the proximal stent 32A may then be deployed by retracting the wire 88 that couples the ends of the belt 86 restraining the proximal stent 32B. As the proximal stent 32A self-expands in an outward radial direction, an outside surface of the proximal stent 32A eventually makes contact with the inside surface 90 of the patient's aorta 79. For embodiments that include tissue engaging barbs 33 on the proximal stent 32A, the barbs may also be oriented and pushed in an outward radial direction so as to make contact and engage the inner surface tissue 90 of the patient's vessel 79, which further secures the proximal anchor member 32 to the patient's vessel 79 as shown in
Once the proximal anchor member 32 has been secured to the inside surface 90 of the patient's vessel 79, the proximal inflatable cuff 62 may then be filled through the inflation port 60 with inflation material injected through an inflation tube 91 of the delivery catheter 75 which may serve to seal an outside surface of the inflatable cuff 62 to the inside surface 83 of the vessel 79. The remaining network of inflatable channels 58 are also filled with pressurized inflation material at the same time which provides a more rigid frame like structure to the graft 12 as shown in
The network of inflatable channels 58 may be partially or fully inflated by injection of a suitable inflation material into the main fill port 60 to provide rigidity to the network of inflatable channels 58 and the main graft 12. In addition, a seal is produced between the inflatable cuff 62 and the inside surface of the abdominal aorta 82. Although it is desirable to partially or fully inflate the network of inflatable channels 58 of the main graft 12 at this stage of the deployment process, such inflation step optionally may be accomplished at a later stage if necessary.
Once the graft member 12 is anchored and the inflatable channels 58 thereof have been filled and expanded, a second delivery catheter 92 that contains the contralateral graft extension 15 may access the contralateral femoral artery directly or through a delivery sheath as discussed above. The second delivery catheter may be advanced proximally, as shown in
Once properly positioned, an outer sheath 94 of the second delivery catheter 92 which may radially restrain the contralateral graft extension 15, may be distally withdrawn while the graft extension 15 remains substantially axially fixed. This axial retraction of the outer sheath 94 of the second delivery catheter 92 deploys the contralateral graft extension 15 so as to allow the graft extension 15 to radially self-expand and engage the inner lumen 30 of the contralateral leg 26 and inner surface of the contralateral iliac artery proximal of the contralateral leg 26 as shown in
For some embodiments, up to the time that the network of inflatable channels 58 have been filled with inflation material which has been cured or hardened, an elongate tether 96 may be used to axially restrain the graft 12 and prevent axial separation of the graft 12 from the delivery catheter 75. This axial restraint may be important for embodiments wherein the inflation tube 91 of the delivery catheter 75 is secured to the fill port 60 of the network of inflatable channels 58 of the graft member 12 by an overlapped slip fit or interference fit only. For some embodiments, the inflation tube 91 may overlap with the fill tube 60 of the graft 12 by about 5 mm to about 25 mm, more specifically, about 10 mm to about 15 mm. The tether 96 loops through the flow lumens 24 and 30 of the ipsilateral and contralateral legs 20 and 26 of the graft member 12 and is secured to a handle on a proximal adapter (not shown) of the delivery catheter 75. The tether 96 is configured to have a length that is short enough to mechanically restrain distal axial movement of the main graft member 12 relative to the delivery catheter 75 so as to prevent decoupling of the inflation tube 91 from the inflation or fill port 60 of the main graft member 12. Once the inflation material has been fully injected into the network of inflatable channels 58 and cured or hardened, the tether 96 may be released and removed to allow distal retraction of the delivery catheter 75 as shown in
Once the tether 96 has been released and the delivery catheter 75 retracted and decoupled from the graft main member 12 and patient's vasculature generally, a third delivery catheter (not shown) which contains the ipsilateral graft extension 14 may be advanced into the patient's vasculature directly or through an ipsilateral delivery sheath as discussed above. The third delivery catheter may have the same features, dimensions and materials as those of the second delivery catheter 92. The third delivery catheter may be advanced proximally through the patient's femoral artery and into the ipsilateral iliac artery 78 until the radially compressed ipsilateral graft extension 14 is in an axial position which overlaps the ipsilateral leg 20 of the graft member 12. Although not shown, this advancement of the third delivery catheter may be carried out in a manner which is the same as or similar to the deployment of the second delivery catheter 92 used for deployment of the contralateral graft extension 15 discussed above. The amount of desired overlap of the graft extension 14 with the ipsilateral leg 20 may once again vary depending on a variety of factors including vessel morphology, degree of vascular disease, patient status and the like. However, for some embodiments, the amount of axial overlap between the ipsilateral graft extension 14 and the ipsilateral leg 20 may be about 1 cm to about 5 cm, more specifically, about 2 cm to about 4 cm.
This overlapped position may also provide for longitudinal overlap between the fluid flow lumen 44 of the graft extension 14 with the fluid flow lumen 24 of the ipsilateral leg 20. Once properly positioned, an outer sheath of the third delivery catheter which may be configured to radially restrain the ipsilateral graft extension 14, may be distally withdrawn while the graft extension 14 remains substantially axially fixed. This axial retraction of the outer sheath of the third delivery catheter deploys the ipsilateral graft extension 14 so as to allow the graft extension 14 to radially self-expand and engage the inner lumen of the ipsilateral leg 20 and inner surface of the ipsilateral iliac artery proximal of the ipsilateral leg 20 as shown in
For some deployment embodiments, the patient's hypogastric arteries may be used to serve as a positioning reference point to ensure that the hypogastric arteries are not blocked by the deployment. Upon such a deployment, the distal end of a graft extension 14 or 15 may be deployed anywhere within a length of the ipsilateral or contralateral leg of the graft 12. Also, although only one graft extension is shown deployed on the ipsilateral side and contralateral side of the graft assembly 10, additional graft extensions 14 and 15 may be deployed within the already deployed graft extensions 14 and 15 in order to achieve a desired length extension of the ipsilateral leg 20 or contralateral leg 26. For some embodiments, about 1 to about 5 graft extensions 14 or 15 may be deployed on either the ipsilateral or contralateral sides of the graft assembly 10. Successive graft extensions 14 and 15 may be deployed within each other so as to longitudinally overlap fluid flow lumens of successive graft extensions.
Graft extensions 14 and 15, which may be interchangeable for some embodiments, or any other suitable extension devices or portions of the main graft section 12 may include a variety of suitable configurations. For some embodiments, graft extensions 14 and 15 may include a PTFE covered helical nitinol stent 51 as discussed above with layers of PTFE having a variety of characteristics. Regarding the stent 51, it may be formed from an elongate resilient element which is helically wound with a plurality of longitudinally spaced turns. Some stent embodiments 51 may be generally helical in configuration with serpentine or other regularly space undulations transverse to the helical path of the elongate stent element as shown in more detail in
For some embodiments of graft extension 14, layers of materials having different properties may be used in combination to achieve a desired clinical performance. For example, some layers of PTFE covering the stent 51 may be permeable, semi-permeable or substantially non-permeable depending on the desired performance and material properties.
The extension 14 may be made by forming the layers of material 100 and 102 together with the stent 51 over a mandrel, such as a cylindrical mandrel (not shown). Once the innermost layer 102 of the extension 14 has been wrapped about a shaped mandrel, a helical nitinol stent, such as helical stent 51, may be placed over the the innermost layered PTFE layer 56 and underlying mandrel. One or more additional layers of low permeability PTFE film or PTFE film having substantially no permeability 100 that does not have the traditional node fibril microstructure may be wrapped or otherwise added over the exterior of the stent 51. The mandrel may then be covered with a flexible tube such that the film and stent is sandwiched under pressure and sintered so as to raise the temperature for the PTFE material to undergo a melt transformation in order to lock in its geometry and strength. The flexible tube (a manufacturing aid not shown) is removed from over the device and the resultant extension is removed from the mandrel.
For some embodiments, the low permeability non-expanded PTFE material 100 may have a non-typical node fibril microstructure with essentially no nodal spacing and very low or no liquid permeability. The extensions 14 and 15 may include about 1 layer to about 5 layers of semi-permeable or substantially non-permeable PTFE material having a thickness of about 0.0001 inches to about 0.005 inches, more specifically, about 0.0004 inches to about 0.001 inches. Examples of such materials are described in U.S. Patent Application publication numbers 2006/0233990 and 2006/0233991 described above which are incorporated by reference in their entirety herein.
For some embodiments, the PTFE material 100 having low permeability or substantially no permeability may be made by providing a PTFE layer and applying a stretching agent, such as an isopar lubricant material, to at least a portion of the PTFE layer and stretching the PTFE layer while the layer is wet with stretching agent. For some embodiments, the PTFE layer may be saturated with stretching agent while being stretched. For some embodiments, the PTFE layer may be stretched by a ratio of about 2:1 to about 20:1. For some embodiments, the wet stretching of the PTFE layer is carried out in a direction transverse to the machine direction of expansion. For some embodiments, the wet stretching of the PTFE layer is carried out at a temperature of about 80 degrees F. to about 130 degrees F., or at a temperature that is just above the glass transition temperature of the PTFE layer material. For some embodiments, the PTFE layer provided is made by extruding a compounded PTFE resin through an extruder to form a PTFE ribbon extrudate. Such a PTFE material 100 may have substantially low porosity, low permeability, no discernable node and fibril structure and a thickness of about 0.00005 inch to about 0.005 inch. Some such PTFE materials may also have a closed cell microstructure with a plurality of interconnected high density regions having no discernable node and fibril structure between the high density regions. Some such PTFE materials may have low or no fluid permeability.
With regard to the above detailed description, like reference numerals used therein refer to like elements that may have the same or similar dimensions, materials and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments of the invention. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.
This application is a continuation application of U.S. patent application Ser. No. 16/231,219, filed Dec. 21, 2018, now U.S. Pat. No. 10,682,222, which is a continuation of U.S. patent application Ser. No. 12/245,620, filed Oct. 3, 2008, now U.S. Pat. No. 10,159,557, which claims priority under 35 U.S.C. section 119(e) from U.S. provisional application Ser. No. 60/977,617 filed Oct. 4, 2007, by Michael V. Chobotov et al. titled “MODULAR VASCULAR GRAFT FOR LOW PROFILE PERCUTANEOUS DELIVERY” which are incorporated by reference herein in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3076737 | Roberts | Feb 1963 | A |
| 3540431 | Uddin | Nov 1970 | A |
| 3631854 | Fryer et al. | Jan 1972 | A |
| 3657744 | Ersek | Apr 1972 | A |
| 3669586 | Kramer | Jun 1972 | A |
| 3814137 | Martinez | Jun 1974 | A |
| 3818511 | Goldberg et al. | Jun 1974 | A |
| 3902198 | Rathjen | Sep 1975 | A |
| 3991767 | Miller et al. | Nov 1976 | A |
| 4096227 | Gore | Jun 1978 | A |
| 4110392 | Yamasaki | Aug 1978 | A |
| 4140126 | Choudhury | Feb 1979 | A |
| 4183102 | Guiset | Jan 1980 | A |
| 4187390 | Gore | Feb 1980 | A |
| 4208745 | Okita | Jun 1980 | A |
| 4214587 | Sakura, Jr. | Jul 1980 | A |
| 4229838 | Mano | Oct 1980 | A |
| 4248924 | Okita | Feb 1981 | A |
| 4330126 | Rumble | May 1982 | A |
| 4385093 | Hubis | May 1983 | A |
| 4416028 | Eriksson et al. | Nov 1983 | A |
| 4434797 | Silander | Mar 1984 | A |
| 4459252 | MacGregor | Jul 1984 | A |
| 4474630 | Planck et al. | Oct 1984 | A |
| 4478665 | Hubis | Oct 1984 | A |
| 4482516 | Bowman et al. | Nov 1984 | A |
| 4497074 | Rey et al. | Feb 1985 | A |
| 4503569 | Dotter | Mar 1985 | A |
| 4512338 | Balko et al. | Apr 1985 | A |
| 4550447 | Seiler, Jr. et al. | Nov 1985 | A |
| 4552707 | How | Nov 1985 | A |
| 4562596 | Komberg | Jan 1986 | A |
| 4577631 | Kreamer | Mar 1986 | A |
| 4580568 | Gianturco | Apr 1986 | A |
| 4592754 | Gupte et al. | Jun 1986 | A |
| 4617932 | Komberg | Oct 1986 | A |
| 4647416 | Seiler, Jr. et al. | Mar 1987 | A |
| 4655769 | Zachariades | Apr 1987 | A |
| 4655771 | Wallsten | Apr 1987 | A |
| 4665906 | Jervis | May 1987 | A |
| 4705517 | DiPisa, Jr. | Nov 1987 | A |
| 4731073 | Robinson | Mar 1988 | A |
| 4733665 | Palmaz | Mar 1988 | A |
| 4739762 | Palmaz | Apr 1988 | A |
| 4740207 | Kreamer | Apr 1988 | A |
| 4743480 | Campbell et al. | May 1988 | A |
| 4760102 | Moriyama et al. | Jul 1988 | A |
| 4776337 | Palmaz | Oct 1988 | A |
| 4787899 | Lazarus | Nov 1988 | A |
| 4816028 | Kapadia et al. | Mar 1989 | A |
| 4830003 | Wolff et al. | May 1989 | A |
| 4856516 | Hillstead | Aug 1989 | A |
| 4871365 | Dumican | Oct 1989 | A |
| 4877661 | House et al. | Oct 1989 | A |
| 4902423 | Bacino | Feb 1990 | A |
| 4932938 | Goldberg et al. | Jun 1990 | A |
| 4941870 | Okada et al. | Jul 1990 | A |
| 4955899 | Della et al. | Sep 1990 | A |
| 4957669 | Primm | Sep 1990 | A |
| 4985296 | Mortimer, Jr. | Jan 1991 | A |
| 4994071 | MacGregor | Feb 1991 | A |
| 4994077 | Dobben | Feb 1991 | A |
| 5019090 | Pinchuk | May 1991 | A |
| 5041126 | Gianturco | Aug 1991 | A |
| 5052998 | Zimmon | Oct 1991 | A |
| 5059211 | Stack et al. | Oct 1991 | A |
| 5064435 | Porter | Nov 1991 | A |
| 5098625 | Huang et al. | Mar 1992 | A |
| 5100422 | Berguer et al. | Mar 1992 | A |
| 5104399 | Lazarus | Apr 1992 | A |
| 5104400 | Berguer et al. | Apr 1992 | A |
| 5104404 | Wolff | Apr 1992 | A |
| 5108424 | Hoffman, Jr. et al. | Apr 1992 | A |
| 5110527 | Harada et al. | May 1992 | A |
| 5116365 | Hillstead | May 1992 | A |
| 5122154 | Rhodes | Jun 1992 | A |
| 5123917 | Lee | Jun 1992 | A |
| 5133732 | Wiktor | Jul 1992 | A |
| 5135536 | Hillstead | Aug 1992 | A |
| 5139480 | Hickle et al. | Aug 1992 | A |
| 5150304 | Berchem et al. | Sep 1992 | A |
| 5151105 | Kwan-Gett | Sep 1992 | A |
| 5152782 | Kowligi et al. | Oct 1992 | A |
| 5156620 | Pigott | Oct 1992 | A |
| 5158548 | Lau et al. | Oct 1992 | A |
| 5163955 | Love | Nov 1992 | A |
| 5167614 | Tessmann | Dec 1992 | A |
| 5171262 | MacGregor | Dec 1992 | A |
| 5192310 | Herweck et al. | Mar 1993 | A |
| 5195984 | Schatz | Mar 1993 | A |
| 5197976 | Herweck et al. | Mar 1993 | A |
| 5197978 | Hess | Mar 1993 | A |
| 5201757 | Heyn et al. | Apr 1993 | A |
| 5202352 | Okada et al. | Apr 1993 | A |
| 5207695 | Trout, III | May 1993 | A |
| 5217483 | Tower | Jun 1993 | A |
| 5219355 | Parodi et al. | Jun 1993 | A |
| 5226913 | Pinchuk | Jul 1993 | A |
| 5234456 | Silvestini | Aug 1993 | A |
| 5250059 | Andreas et al. | Oct 1993 | A |
| 5275622 | Lazarus et al. | Jan 1994 | A |
| 5282823 | Schwartz et al. | Feb 1994 | A |
| 5282824 | Gianturco | Feb 1994 | A |
| 5282847 | Trescony et al. | Feb 1994 | A |
| 5290305 | Inoue | Mar 1994 | A |
| 5292331 | Boneau | Mar 1994 | A |
| 5304200 | Spaulding | Apr 1994 | A |
| 5314472 | Fontaine | May 1994 | A |
| 5316023 | Palmaz et al. | May 1994 | A |
| 5320100 | Herweck et al. | Jun 1994 | A |
| 5321109 | Bosse et al. | Jun 1994 | A |
| 5330528 | Lazim | Jul 1994 | A |
| 5334164 | Guy et al. | Aug 1994 | A |
| 5334201 | Cowan | Aug 1994 | A |
| 5344426 | Lau et al. | Sep 1994 | A |
| 5344444 | Glastra | Sep 1994 | A |
| 5344451 | Dayton | Sep 1994 | A |
| 5350398 | Pavcnik | Sep 1994 | A |
| 5354310 | Garnic et al. | Oct 1994 | A |
| 5354329 | Whalen | Oct 1994 | A |
| 5360443 | Barone et al. | Nov 1994 | A |
| 5365996 | Crook | Nov 1994 | A |
| 5366504 | Andersen et al. | Nov 1994 | A |
| 5370682 | Schmitt | Dec 1994 | A |
| 5370691 | Samson | Dec 1994 | A |
| 5374473 | Knox et al. | Dec 1994 | A |
| 5382261 | Palmaz | Jan 1995 | A |
| 5383892 | Cardon et al. | Jan 1995 | A |
| 5383928 | Scott et al. | Jan 1995 | A |
| 5387235 | Chuter et al. | Feb 1995 | A |
| 5389106 | Tower et al. | Feb 1995 | A |
| 5391147 | Imran et al. | Feb 1995 | A |
| 5397345 | Lazarus | Mar 1995 | A |
| 5405377 | Cragg | Apr 1995 | A |
| 5405378 | Strecker | Apr 1995 | A |
| 5405379 | Lane | Apr 1995 | A |
| 5411550 | Herweck et al. | May 1995 | A |
| 5415634 | Glynn et al. | May 1995 | A |
| 5423851 | Samuels | Jun 1995 | A |
| 5433909 | Martakos et al. | Jul 1995 | A |
| 5437900 | Kuzowski | Aug 1995 | A |
| 5441515 | Khosravi et al. | Aug 1995 | A |
| 5443458 | Eury | Aug 1995 | A |
| 5443498 | Fountaine | Aug 1995 | A |
| 5445646 | Euteneuer et al. | Aug 1995 | A |
| 5447152 | Kohsai et al. | Sep 1995 | A |
| 5449373 | Pinchasik et al. | Sep 1995 | A |
| 5456713 | Chuter | Oct 1995 | A |
| 5464419 | Glastra | Nov 1995 | A |
| 5464449 | Ryan et al. | Nov 1995 | A |
| 5466509 | Kowllgl et al. | Nov 1995 | A |
| 5474824 | Martakos et al. | Dec 1995 | A |
| 5476506 | Lunn | Dec 1995 | A |
| 5476589 | Bacino | Dec 1995 | A |
| 5478330 | Imran et al. | Dec 1995 | A |
| 5480423 | Ravenscroft et al. | Jan 1996 | A |
| 5489295 | Piplani et al. | Feb 1996 | A |
| 5505887 | Zdrahala et al. | Apr 1996 | A |
| 5507769 | Marin et al. | Apr 1996 | A |
| 5507770 | Turk | Apr 1996 | A |
| 5512360 | King | Apr 1996 | A |
| 5514154 | Lau et al. | May 1996 | A |
| 5522880 | Barone et al. | Jun 1996 | A |
| 5522881 | Lentz | Jun 1996 | A |
| 5522883 | Slater et al. | Jun 1996 | A |
| 5524633 | Heaven et al. | Jun 1996 | A |
| 5527353 | Schmitt | Jun 1996 | A |
| 5527355 | Ahn | Jun 1996 | A |
| 5529653 | Glastra | Jun 1996 | A |
| 5529820 | Nomi et al. | Jun 1996 | A |
| 5534024 | Rogers et al. | Jul 1996 | A |
| 5536274 | Neuss | Jul 1996 | A |
| 5545135 | Iacob et al. | Aug 1996 | A |
| 5549662 | Fordenbacher | Aug 1996 | A |
| 5549663 | Cottone, Jr. | Aug 1996 | A |
| 5552100 | Shannon et al. | Sep 1996 | A |
| 5554180 | Turk | Sep 1996 | A |
| 5554181 | Das | Sep 1996 | A |
| 5554183 | Nazari | Sep 1996 | A |
| 5554185 | Block et al. | Sep 1996 | A |
| 5556414 | Turi | Sep 1996 | A |
| 5556426 | Popadiuk et al. | Sep 1996 | A |
| 5560986 | Mortimer, Jr. | Oct 1996 | A |
| 5562697 | Christiansen | Oct 1996 | A |
| 5562724 | Vorwerk et al. | Oct 1996 | A |
| 5562726 | Chuter | Oct 1996 | A |
| 5562727 | Turk et al. | Oct 1996 | A |
| 5562728 | Lazarus et al. | Oct 1996 | A |
| 5569295 | Lam | Oct 1996 | A |
| 5571171 | Barone et al. | Nov 1996 | A |
| 5571172 | Chin | Nov 1996 | A |
| 5571173 | Parodi | Nov 1996 | A |
| 5575817 | Martin | Nov 1996 | A |
| 5575818 | Pinchuk | Nov 1996 | A |
| 5578071 | Parodi | Nov 1996 | A |
| 5578072 | Barone et al. | Nov 1996 | A |
| 5588964 | Imran et al. | Dec 1996 | A |
| 5591195 | Taheri et al. | Jan 1997 | A |
| 5591197 | Orth et al. | Jan 1997 | A |
| 5591229 | Parodi | Jan 1997 | A |
| 5597378 | Jervis | Jan 1997 | A |
| 5603721 | Lau et al. | Feb 1997 | A |
| 5607478 | Lentz et al. | Mar 1997 | A |
| 5609624 | Kalis | Mar 1997 | A |
| 5609625 | Piplani et al. | Mar 1997 | A |
| 5609627 | Goicoechea et al. | Mar 1997 | A |
| 5609628 | Keranen | Mar 1997 | A |
| 5609629 | Fearnont | Mar 1997 | A |
| 5612885 | Love | Mar 1997 | A |
| 5618301 | Hauenstein et al. | Apr 1997 | A |
| 5620763 | House et al. | Apr 1997 | A |
| 5626599 | Bourne et al. | May 1997 | A |
| 5628783 | Quiachon et al. | May 1997 | A |
| 5628786 | Banas et al. | May 1997 | A |
| 5628788 | Pinchuk | May 1997 | A |
| 5630829 | Lauterjung | May 1997 | A |
| 5632772 | Alcime et al. | May 1997 | A |
| 5632840 | Campbell | May 1997 | A |
| 5639278 | Dereume | Jun 1997 | A |
| 5641373 | Shannon et al. | Jun 1997 | A |
| 5645915 | Kranzler et al. | Jul 1997 | A |
| 5649978 | Samson | Jul 1997 | A |
| 5653745 | Trescony et al. | Aug 1997 | A |
| 5653746 | Schmitt | Aug 1997 | A |
| 5656029 | Imran et al. | Aug 1997 | A |
| 5662675 | Stockert et al. | Sep 1997 | A |
| 5662700 | Lazarus | Sep 1997 | A |
| 5665115 | Cragg | Sep 1997 | A |
| 5665117 | Rhodes | Sep 1997 | A |
| 5667523 | Bynon et al. | Sep 1997 | A |
| 5669936 | Lazarus | Sep 1997 | A |
| 5676671 | Inoue | Oct 1997 | A |
| 5676696 | Marcade | Oct 1997 | A |
| 5676697 | McDonald | Oct 1997 | A |
| 5681346 | Orth et al. | Oct 1997 | A |
| 5683449 | Marcade | Nov 1997 | A |
| 5683451 | Lenker et al. | Nov 1997 | A |
| 5683453 | Palmaz | Nov 1997 | A |
| 5690644 | Yurek et al. | Nov 1997 | A |
| 5693083 | Baker et al. | Dec 1997 | A |
| 5693084 | Chuter | Dec 1997 | A |
| 5693087 | Parodi | Dec 1997 | A |
| 5693088 | Lazarus | Dec 1997 | A |
| 5697968 | Rogers et al. | Dec 1997 | A |
| 5697971 | Fischell et al. | Dec 1997 | A |
| 5700285 | Myers et al. | Dec 1997 | A |
| 5707378 | Ahn et al. | Jan 1998 | A |
| 5707388 | Lauterjung | Jan 1998 | A |
| 5708044 | Branca | Jan 1998 | A |
| 5709701 | Parodi | Jan 1998 | A |
| 5709703 | Lukie et al. | Jan 1998 | A |
| 5712315 | Dolan | Jan 1998 | A |
| 5713917 | Leonhardt et al. | Feb 1998 | A |
| 5716393 | Lindenberg et al. | Feb 1998 | A |
| 5716395 | Myers et al. | Feb 1998 | A |
| 5718159 | Thompson | Feb 1998 | A |
| 5718973 | Lewis et al. | Feb 1998 | A |
| 5720776 | Chuter et al. | Feb 1998 | A |
| 5723004 | Dereume et al. | Mar 1998 | A |
| 5725547 | Chuter | Mar 1998 | A |
| 5725549 | Lam | Mar 1998 | A |
| 5728131 | Frantzen et al. | Mar 1998 | A |
| 5733303 | Israel et al. | Mar 1998 | A |
| 5733325 | Robinson et al. | Mar 1998 | A |
| 5735892 | Myers et al. | Apr 1998 | A |
| 5735893 | Lau et al. | Apr 1998 | A |
| 5735897 | Buirge | Apr 1998 | A |
| 5741324 | Glastra | Apr 1998 | A |
| 5741325 | Chaikof et al. | Apr 1998 | A |
| 5747128 | Campbell et al. | May 1998 | A |
| 5749880 | Banas et al. | May 1998 | A |
| 5749894 | Engleson | May 1998 | A |
| 5749920 | Quiachon et al. | May 1998 | A |
| 5749921 | Lenker et al. | May 1998 | A |
| 5755772 | Evans et al. | May 1998 | A |
| 5755776 | Al-Saadon | May 1998 | A |
| 5766203 | Imran et al. | Jun 1998 | A |
| 5769882 | Fogarty et al. | Jun 1998 | A |
| 5769885 | Quiachon et al. | Jun 1998 | A |
| 5769887 | Brown et al. | Jun 1998 | A |
| 5772884 | Tanaka et al. | Jun 1998 | A |
| 5776142 | Gunderson | Jul 1998 | A |
| 5776161 | Globerman | Jul 1998 | A |
| 5776183 | Kanesaka et al. | Jul 1998 | A |
| 5780807 | Saunders | Jul 1998 | A |
| 5782789 | Herweck et al. | Jul 1998 | A |
| 5782838 | Beyar et al. | Jul 1998 | A |
| 5782904 | White et al. | Jul 1998 | A |
| 5782909 | Quiachon et al. | Jul 1998 | A |
| 5785679 | Abolfathi et al. | Jul 1998 | A |
| 5788626 | Thompson | Aug 1998 | A |
| 5789047 | Sasaki et al. | Aug 1998 | A |
| 5797951 | Mueller | Aug 1998 | A |
| 5798924 | Eufinger et al. | Aug 1998 | A |
| 5799384 | Schwartz et al. | Sep 1998 | A |
| 5800508 | Goicoechea et al. | Sep 1998 | A |
| 5800512 | Lentz et al. | Sep 1998 | A |
| 5800515 | Nadal et al. | Sep 1998 | A |
| 5800518 | Piplani et al. | Sep 1998 | A |
| 5800522 | Campbell et al. | Sep 1998 | A |
| 5800524 | Borghi | Sep 1998 | A |
| 5800526 | Anderson et al. | Sep 1998 | A |
| 5810870 | Meyers et al. | Sep 1998 | A |
| 5810872 | Kanesaka et al. | Sep 1998 | A |
| 5814405 | Branca et al. | Sep 1998 | A |
| 5817102 | Liann et al. | Oct 1998 | A |
| 5824037 | Fogarty et al. | Oct 1998 | A |
| 5824039 | Piplani et al. | Oct 1998 | A |
| 5824041 | Lenker et al. | Oct 1998 | A |
| 5824042 | Lombardi et al. | Oct 1998 | A |
| 5824044 | Quiachon et al. | Oct 1998 | A |
| 5824046 | Smith et al. | Oct 1998 | A |
| 5824058 | Ravenscroft et al. | Oct 1998 | A |
| 5827289 | Reiley et al. | Oct 1998 | A |
| 5827310 | Spoeistra | Oct 1998 | A |
| 5827320 | Richter et al. | Oct 1998 | A |
| 5827321 | Roubin et al. | Oct 1998 | A |
| 5833651 | Donovan et al. | Nov 1998 | A |
| 5833707 | Mcintyre et al. | Nov 1998 | A |
| 5836964 | Richter et al. | Nov 1998 | A |
| 5836966 | St. Germain | Nov 1998 | A |
| 5840775 | Howard, Jr. et al. | Nov 1998 | A |
| 5843158 | Lenker et al. | Dec 1998 | A |
| 5843160 | Rhodes | Dec 1998 | A |
| 5843162 | Inoue | Dec 1998 | A |
| 5843164 | Frantzen et al. | Dec 1998 | A |
| 5843166 | Lentz et al. | Dec 1998 | A |
| 5843167 | Dwyer et al. | Dec 1998 | A |
| 5843170 | Ahn | Dec 1998 | A |
| 5843173 | Shannon et al. | Dec 1998 | A |
| 5843175 | Frantzen | Dec 1998 | A |
| 5853419 | Imran | Dec 1998 | A |
| 5855598 | Pinchuk | Jan 1999 | A |
| 5858556 | Eckert et al. | Jan 1999 | A |
| 5861027 | Trapp | Jan 1999 | A |
| 5871536 | Lazarus | Feb 1999 | A |
| 5871537 | Holman | Feb 1999 | A |
| 5871538 | Dereume | Feb 1999 | A |
| 5873906 | Lau et al. | Feb 1999 | A |
| 5876432 | Lau et al. | Mar 1999 | A |
| 5891193 | Robinson et al. | Apr 1999 | A |
| 5904713 | Leschinsky | May 1999 | A |
| 5906619 | Olson et al. | May 1999 | A |
| 5906641 | Thompson et al. | May 1999 | A |
| 5910168 | Meyers et al. | Jun 1999 | A |
| 5910277 | IshIno et al. | Jun 1999 | A |
| 5911754 | Kanesaka et al. | Jun 1999 | A |
| 5916264 | Von Oepen et al. | Jun 1999 | A |
| 5919204 | Lukic et al. | Jul 1999 | A |
| 5922020 | Klein et al. | Jul 1999 | A |
| 5925061 | Ogi et al. | Jul 1999 | A |
| 5925075 | Myers et al. | Jul 1999 | A |
| 5931865 | Silverman et al. | Aug 1999 | A |
| 5935667 | Calcote et al. | Aug 1999 | A |
| 5939198 | Howard, Jr. et al. | Aug 1999 | A |
| 5944750 | Tanner et al. | Aug 1999 | A |
| 5948016 | Jang | Sep 1999 | A |
| 5954729 | Bachmann et al. | Sep 1999 | A |
| 5955016 | Goldfarb | Sep 1999 | A |
| 5957973 | Quiachon et al. | Sep 1999 | A |
| 5961545 | Lentz et al. | Oct 1999 | A |
| 5961546 | Robinson et al. | Oct 1999 | A |
| 5968068 | Dehdashtian et al. | Oct 1999 | A |
| 5968090 | Ratcliff et al. | Oct 1999 | A |
| 5972023 | Tanner et al. | Oct 1999 | A |
| 5972027 | Johnson | Oct 1999 | A |
| 5972441 | Campbell et al. | Oct 1999 | A |
| 5976155 | Foreman et al. | Nov 1999 | A |
| 5976179 | Inoue | Nov 1999 | A |
| 5976192 | McIntyre et al. | Nov 1999 | A |
| 5976650 | Campbell et al. | Nov 1999 | A |
| 5980530 | Willard et al. | Nov 1999 | A |
| 5980570 | Simpson | Nov 1999 | A |
| 5984955 | Wisselink | Nov 1999 | A |
| 5984956 | Tweden et al. | Nov 1999 | A |
| 5984964 | Roberts et al. | Nov 1999 | A |
| 5989287 | Yang et al. | Nov 1999 | A |
| 5993481 | Marcade et al. | Nov 1999 | A |
| 5993489 | Lewis et al. | Nov 1999 | A |
| 5997573 | Quijano et al. | Dec 1999 | A |
| 6001123 | Lau | Dec 1999 | A |
| 6004346 | Wolff et al. | Dec 1999 | A |
| 6004347 | McNamara et al. | Dec 1999 | A |
| 6004348 | Banas et al. | Dec 1999 | A |
| 6007575 | Samuels | Dec 1999 | A |
| 6015429 | Lau et al. | Jan 2000 | A |
| 6015431 | Thornton et al. | Jan 2000 | A |
| 6015432 | Rakos et al. | Jan 2000 | A |
| 6017362 | Lau | Jan 2000 | A |
| 6017364 | Lazarus | Jan 2000 | A |
| 6019778 | Wilson et al. | Feb 2000 | A |
| 6019779 | Thorud | Feb 2000 | A |
| 6019787 | Richard et al. | Feb 2000 | A |
| 6022359 | Frantzen | Feb 2000 | A |
| 6024763 | Lenker et al. | Feb 2000 | A |
| 6025044 | Campbell et al. | Feb 2000 | A |
| 6027779 | Campbell et al. | Feb 2000 | A |
| 6027811 | Campbell et al. | Feb 2000 | A |
| 6030413 | Lazarus | Feb 2000 | A |
| 6030414 | Taheri | Feb 2000 | A |
| 6030415 | Chuter | Feb 2000 | A |
| 6036640 | Corace et al. | Mar 2000 | A |
| 6036702 | Bachinski et al. | Mar 2000 | A |
| 6036723 | Anidjar et al. | Mar 2000 | A |
| 6036724 | Lentz et al. | Mar 2000 | A |
| 6036725 | Avellanet | Mar 2000 | A |
| 6039754 | Caro | Mar 2000 | A |
| 6039758 | Quiachon et al. | Mar 2000 | A |
| 6042589 | Marianne | Mar 2000 | A |
| 6042605 | Martin et al. | Mar 2000 | A |
| 6042606 | Frantzen | Mar 2000 | A |
| 6045557 | White et al. | Apr 2000 | A |
| 6048484 | House et al. | Apr 2000 | A |
| 6051020 | Goicoechea et al. | Apr 2000 | A |
| 6053943 | Edwin et al. | Apr 2000 | A |
| 6059821 | Anidjar et al. | May 2000 | A |
| 6059823 | Holman et al. | May 2000 | A |
| 6060534 | Ronan et al. | May 2000 | A |
| 6063114 | Nash et al. | May 2000 | A |
| 6068626 | Harrington et al. | May 2000 | A |
| 6070589 | Keith et al. | Jun 2000 | A |
| 6074341 | Anderson et al. | Jun 2000 | A |
| 6075180 | Sharber et al. | Jun 2000 | A |
| 6077296 | Shokoohi et al. | Jun 2000 | A |
| 6077297 | Robinson et al. | Jun 2000 | A |
| 6077298 | Tu et al. | Jun 2000 | A |
| 6090128 | Douglas | Jul 2000 | A |
| 6093203 | Uflacker | Jul 2000 | A |
| 6096052 | Callister et al. | Aug 2000 | A |
| 6096070 | Ragheb et al. | Aug 2000 | A |
| 6098630 | Papazoglou | Aug 2000 | A |
| 6102918 | Kerr | Aug 2000 | A |
| 6102938 | Evans et al. | Aug 2000 | A |
| 6102940 | Robichon et al. | Aug 2000 | A |
| 6103172 | Newman et al. | Aug 2000 | A |
| 6106548 | Roubin et al. | Aug 2000 | A |
| 6110198 | Fogarty et al. | Aug 2000 | A |
| 6113628 | Borghi | Sep 2000 | A |
| 6117168 | Yang et al. | Sep 2000 | A |
| 6123722 | Fogarty et al. | Sep 2000 | A |
| 6124523 | Banas et al. | Sep 2000 | A |
| 6126685 | Lenker et al. | Oct 2000 | A |
| 6129756 | Kugler et al. | Oct 2000 | A |
| 6132457 | Chobotov | Oct 2000 | A |
| 6132459 | Piplani et al. | Oct 2000 | A |
| 6139572 | Campbell et al. | Oct 2000 | A |
| 6142973 | Carleton et al. | Nov 2000 | A |
| 6143014 | Dehdashtian et al. | Nov 2000 | A |
| 6143015 | Nobles | Nov 2000 | A |
| 6143016 | Bleam et al. | Nov 2000 | A |
| 6143021 | Staehle | Nov 2000 | A |
| 6143022 | Shull et al. | Nov 2000 | A |
| 6146389 | Geitz | Nov 2000 | A |
| 6146416 | Andersen et al. | Nov 2000 | A |
| 6146417 | Ischinger | Nov 2000 | A |
| 6149665 | Gabbay | Nov 2000 | A |
| 6149681 | Houser et al. | Nov 2000 | A |
| 6149682 | Frid | Nov 2000 | A |
| 6152944 | Holman et al. | Nov 2000 | A |
| 6152956 | Pierce | Nov 2000 | A |
| 6156063 | Douglas | Dec 2000 | A |
| 6156064 | Chouinard | Dec 2000 | A |
| 6159229 | Jendersee et al. | Dec 2000 | A |
| 6159237 | Alt et al. | Dec 2000 | A |
| 6159238 | Killion et al. | Dec 2000 | A |
| 6159239 | Greenhalgh | Dec 2000 | A |
| 6159565 | Campbell et al. | Dec 2000 | A |
| 6162243 | Gray et al. | Dec 2000 | A |
| 6162245 | Jayaraman | Dec 2000 | A |
| 6162246 | Barone | Dec 2000 | A |
| 6165210 | Lau et al. | Dec 2000 | A |
| 6165211 | Thompson | Dec 2000 | A |
| 6165212 | Dereume et al. | Dec 2000 | A |
| 6165213 | Goicoechea et al. | Dec 2000 | A |
| 6165214 | Lazarus | Dec 2000 | A |
| 6168610 | Marin et al. | Jan 2001 | B1 |
| 6168614 | Andersen et al. | Jan 2001 | B1 |
| 6168616 | Brown, III | Jan 2001 | B1 |
| 6168617 | Blaeser et al. | Jan 2001 | B1 |
| 6168618 | Frantzen | Jan 2001 | B1 |
| 6168619 | Dinh et al. | Jan 2001 | B1 |
| 6168620 | Kerr | Jan 2001 | B1 |
| 6174326 | Kitaoka et al. | Jan 2001 | B1 |
| 6183481 | Lee et al. | Feb 2001 | B1 |
| 6183504 | Inoue | Feb 2001 | B1 |
| 6187034 | Frantzen | Feb 2001 | B1 |
| 6187036 | Shaolian et al. | Feb 2001 | B1 |
| 6187054 | Colone et al. | Feb 2001 | B1 |
| 6193745 | Fogarty et al. | Feb 2001 | B1 |
| 6196230 | Hall et al. | Mar 2001 | B1 |
| 6197046 | Piplani et al. | Mar 2001 | B1 |
| 6197049 | Shaolian et al. | Mar 2001 | B1 |
| 6200339 | Leschinsky et al. | Mar 2001 | B1 |
| 6203550 | Olson | Mar 2001 | B1 |
| 6203568 | Lombardi et al. | Mar 2001 | B1 |
| 6203569 | Wijay | Mar 2001 | B1 |
| 6203735 | Edwin et al. | Mar 2001 | B1 |
| 6203779 | Ricci et al. | Mar 2001 | B1 |
| 6210422 | Douglas | Apr 2001 | B1 |
| 6210434 | Quiachon et al. | Apr 2001 | B1 |
| 6210435 | Piplani et al. | Apr 2001 | B1 |
| 6214038 | Piplani et al. | Apr 2001 | B1 |
| 6214039 | Banas et al. | Apr 2001 | B1 |
| 6217608 | Penn et al. | Apr 2001 | B1 |
| 6221102 | Baker et al. | Apr 2001 | B1 |
| 6224609 | Ressemann et al. | May 2001 | B1 |
| 6224625 | Jayaraman | May 2001 | B1 |
| 6231562 | Khosravi | May 2001 | B1 |
| 6235050 | Quiachon et al. | May 2001 | B1 |
| 6235051 | Murphy | May 2001 | B1 |
| 6238432 | Parodi | May 2001 | B1 |
| 6240616 | Yan | Jun 2001 | B1 |
| 6241759 | Piplani et al. | Jun 2001 | B1 |
| 6245097 | Inoue | Jun 2001 | B1 |
| 6245099 | Edwin et al. | Jun 2001 | B1 |
| 6245100 | Davila et al. | Jun 2001 | B1 |
| 6245101 | Drasler et al. | Jun 2001 | B1 |
| 6245102 | Jayaraman | Jun 2001 | B1 |
| 6248116 | Chevillon et al. | Jun 2001 | B1 |
| 6251132 | Ravenscroft et al. | Jun 2001 | B1 |
| 6251136 | Guruwaiya et al. | Jun 2001 | B1 |
| 6254593 | Wilson | Jul 2001 | B1 |
| 6254632 | Wu et al. | Jul 2001 | B1 |
| 6258073 | Mauch | Jul 2001 | B1 |
| 6258114 | Konya et al. | Jul 2001 | B1 |
| 6258116 | Hojeibane | Jul 2001 | B1 |
| 6261316 | Shaolian et al. | Jul 2001 | B1 |
| 6261317 | Inoue | Jul 2001 | B1 |
| 6264662 | Lauterjung | Jul 2001 | B1 |
| 6264684 | Banas et al. | Jul 2001 | B1 |
| 6267783 | Letendre et al. | Jul 2001 | B1 |
| 6267834 | Shannon et al. | Jul 2001 | B1 |
| 6270524 | Kim | Aug 2001 | B1 |
| 6270525 | Letendre et al. | Aug 2001 | B1 |
| 6270707 | Hon et al. | Aug 2001 | B1 |
| 6273909 | Kugler et al. | Aug 2001 | B1 |
| 6273910 | Limon | Aug 2001 | B1 |
| 6273911 | Cox et al. | Aug 2001 | B1 |
| 6280457 | Wallace et al. | Aug 2001 | B1 |
| 6280466 | Kugler et al. | Aug 2001 | B1 |
| 6280467 | Leonhardt et al. | Aug 2001 | B1 |
| 6283991 | Cox et al. | Sep 2001 | B1 |
| 6287315 | Wijeratne et al. | Sep 2001 | B1 |
| 6287329 | Duarig et al. | Sep 2001 | B1 |
| 6287330 | Johansson et al. | Sep 2001 | B1 |
| 6287335 | Drasler et al. | Sep 2001 | B1 |
| 6287336 | Globerman et al. | Sep 2001 | B1 |
| 6290728 | Phelps et al. | Sep 2001 | B1 |
| 6293966 | Frantzen | Sep 2001 | B1 |
| 6293968 | Taheri | Sep 2001 | B1 |
| 6293969 | Chuter | Sep 2001 | B1 |
| 6296661 | Davila et al. | Oct 2001 | B1 |
| 6302891 | Nadal | Oct 2001 | B1 |
| 6302905 | Goldstein et al. | Oct 2001 | B1 |
| 6302906 | Goicoechea et al. | Oct 2001 | B1 |
| 6302908 | Parodi | Oct 2001 | B1 |
| 6303100 | Ricci et al. | Oct 2001 | B1 |
| 6306141 | Jervis | Oct 2001 | B1 |
| 6306145 | Laschinsky | Oct 2001 | B1 |
| 6306164 | Kujawski | Oct 2001 | B1 |
| 6306165 | Patnaik et al. | Oct 2001 | B1 |
| 6312458 | Golds | Nov 2001 | B1 |
| 6312460 | Drasler et al. | Nov 2001 | B2 |
| 6312462 | McDermott et al. | Nov 2001 | B1 |
| 6315791 | Gingras et al. | Nov 2001 | B1 |
| 6319276 | Holman et al. | Nov 2001 | B1 |
| 6319278 | Quinn | Nov 2001 | B1 |
| 6319279 | Shannon et al. | Nov 2001 | B1 |
| 6322587 | Quiachon et al. | Nov 2001 | B1 |
| 6325819 | Pavcnik et al. | Dec 2001 | B1 |
| 6325823 | Horzewski et al. | Dec 2001 | B1 |
| 6325824 | Limon | Dec 2001 | B2 |
| 6325825 | Kula et al. | Dec 2001 | B1 |
| 6328762 | Anderson et al. | Dec 2001 | B1 |
| 6331186 | Wang et al. | Dec 2001 | B1 |
| 6331188 | Lau et al. | Dec 2001 | B1 |
| 6331190 | Shokoohi | Dec 2001 | B1 |
| 6331191 | Chobotov | Dec 2001 | B1 |
| 6334869 | Leonhardt et al. | Jan 2002 | B1 |
| 6336937 | Vonesh et al. | Jan 2002 | B1 |
| 6344044 | Fulkerson et al. | Feb 2002 | B1 |
| 6344054 | Parodi | Feb 2002 | B1 |
| 6344055 | Shukov | Feb 2002 | B1 |
| 6346118 | Baker et al. | Feb 2002 | B1 |
| 6346119 | Kuwahara et al. | Feb 2002 | B1 |
| 6348065 | Brown et al. | Feb 2002 | B1 |
| 6350277 | Kocur | Feb 2002 | B1 |
| 6352553 | Van der Burg et al. | Mar 2002 | B1 |
| 6352561 | Leopold et al. | Mar 2002 | B1 |
| 6355055 | Waksman et al. | Mar 2002 | B1 |
| 6355056 | Pnheiro | Mar 2002 | B1 |
| 6355060 | Lenker et al. | Mar 2002 | B1 |
| 6355063 | Calcote | Mar 2002 | B1 |
| 6357104 | Myers | Mar 2002 | B1 |
| 6358276 | Edwin et al. | Mar 2002 | B1 |
| 6358284 | Fearnot et al. | Mar 2002 | B1 |
| 6361637 | Martin et al. | Mar 2002 | B2 |
| 6363938 | Saadat | Apr 2002 | B2 |
| 6364856 | Ding et al. | Apr 2002 | B1 |
| 6364904 | Smith | Apr 2002 | B1 |
| 6368346 | Jadhav | Apr 2002 | B1 |
| 6368347 | Maini et al. | Apr 2002 | B1 |
| 6368355 | Uflacker | Apr 2002 | B1 |
| 6371979 | Beyar et al. | Apr 2002 | B1 |
| 6372136 | Nakatsuka | Apr 2002 | B1 |
| 6375787 | Lukic | Apr 2002 | B1 |
| 6379381 | Hossainy et al. | Apr 2002 | B1 |
| 6379382 | Yang | Apr 2002 | B1 |
| 6379392 | Walak | Apr 2002 | B1 |
| 6383213 | Wilson et al. | May 2002 | B2 |
| 6383214 | Banas et al. | May 2002 | B1 |
| 6387119 | Wolf et al. | May 2002 | B2 |
| 6387124 | Buscemi et al. | May 2002 | B1 |
| 6391050 | Broome | May 2002 | B1 |
| 6391052 | Buirge et al. | May 2002 | B2 |
| 6395019 | Chobotov | May 2002 | B2 |
| 6395022 | Piplani et al. | May 2002 | B1 |
| 6395208 | Herweck et al. | May 2002 | B1 |
| 6398803 | Layne et al. | Jun 2002 | B1 |
| 6402779 | Colone et al. | Jun 2002 | B1 |
| 6406489 | Richter et al. | Jun 2002 | B1 |
| 6409749 | Maynard | Jun 2002 | B1 |
| 6409750 | Hyodoh | Jun 2002 | B1 |
| 6409754 | Smith et al. | Jun 2002 | B1 |
| 6409756 | Murphy | Jun 2002 | B1 |
| 6409757 | Trout et al. | Jun 2002 | B1 |
| 6409761 | Jang | Jun 2002 | B1 |
| 6413269 | Bui et al. | Jul 2002 | B1 |
| 6416535 | Lazarus | Jul 2002 | B1 |
| 6416536 | Yee | Jul 2002 | B1 |
| 6416537 | Martakos et al. | Jul 2002 | B1 |
| 6416538 | Ley et al. | Jul 2002 | B1 |
| 6416539 | Hassdenteufel | Jul 2002 | B1 |
| 6416542 | Marcade et al. | Jul 2002 | B1 |
| 6419701 | Cook et al. | Jul 2002 | B1 |
| 6423084 | St. Germain | Jul 2002 | B1 |
| 6423089 | Gingras et al. | Jul 2002 | B1 |
| 6423090 | Hancock | Jul 2002 | B1 |
| 6425855 | Tomonto | Jul 2002 | B2 |
| 6425898 | Wilson et al. | Jul 2002 | B1 |
| 6428506 | Simhambhatla et al. | Aug 2002 | B1 |
| 6428565 | Wisselink | Aug 2002 | B1 |
| 6428566 | Holt | Aug 2002 | B1 |
| 6428567 | Wilson et al. | Aug 2002 | B2 |
| 6428569 | Brown | Aug 2002 | B1 |
| 6428570 | Globerman | Aug 2002 | B1 |
| 6428571 | Lentz et al. | Aug 2002 | B1 |
| 6432129 | DiCaprio | Aug 2002 | B2 |
| 6432131 | Ravenscroft | Aug 2002 | B1 |
| 6432132 | Cottone et al. | Aug 2002 | B1 |
| 6436104 | Hoieibane | Aug 2002 | B2 |
| 6436133 | Furst et al. | Aug 2002 | B1 |
| 6436134 | Richter et al. | Aug 2002 | B2 |
| 6436135 | Goldfarb | Aug 2002 | B1 |
| 6440165 | Richter et al. | Aug 2002 | B1 |
| 6443941 | Slepian et al. | Sep 2002 | B1 |
| 6443979 | Stalker et al. | Sep 2002 | B1 |
| 6443981 | Colone et al. | Sep 2002 | B1 |
| 6447501 | Solar et al. | Sep 2002 | B1 |
| 6447522 | Gambale et al. | Sep 2002 | B2 |
| 6451047 | McCrea et al. | Sep 2002 | B2 |
| 6451050 | Rudakov et al. | Sep 2002 | B1 |
| 6451051 | Drasler et al. | Sep 2002 | B2 |
| 6451053 | Dehdashtian et al. | Sep 2002 | B1 |
| 6454796 | Barkman et al. | Sep 2002 | B1 |
| 6461381 | Israel et al. | Oct 2002 | B2 |
| 6464720 | Boatman et al. | Oct 2002 | B2 |
| 6464721 | Marcade et al. | Oct 2002 | B1 |
| 6464722 | Israel et al. | Oct 2002 | B2 |
| 6471718 | Staehle et al. | Oct 2002 | B1 |
| 6471720 | Ehr et al. | Oct 2002 | B1 |
| 6471721 | Dang | Oct 2002 | B1 |
| 6471722 | Inoue | Oct 2002 | B1 |
| 6475166 | Escano | Nov 2002 | B1 |
| 6475208 | Mauch | Nov 2002 | B2 |
| 6475236 | Roubin et al. | Nov 2002 | B1 |
| 6475237 | Drasler | Nov 2002 | B2 |
| 6475238 | Fedida | Nov 2002 | B1 |
| 6475466 | Ricci et al. | Nov 2002 | B1 |
| 6478807 | Foreman et al. | Nov 2002 | B1 |
| 6478815 | Alt | Nov 2002 | B1 |
| 6478816 | Kveen et al. | Nov 2002 | B2 |
| 6482227 | Solovay | Nov 2002 | B1 |
| 6485507 | Walak et al. | Nov 2002 | B1 |
| 6485508 | McGuinness | Nov 2002 | B1 |
| 6485509 | Killion et al. | Nov 2002 | B2 |
| 6485511 | Lau et al. | Nov 2002 | B2 |
| 6485513 | Fan | Nov 2002 | B1 |
| 6485515 | Strecker | Nov 2002 | B2 |
| 6485524 | Strecker | Nov 2002 | B2 |
| 6488694 | Lau et al. | Dec 2002 | B1 |
| 6488700 | Klumb et al. | Dec 2002 | B2 |
| 6488701 | Nolting et al. | Dec 2002 | B1 |
| 6488705 | Schmitt et al. | Dec 2002 | B2 |
| 6491718 | Ahmad | Dec 2002 | B1 |
| 6491719 | Fogary et al. | Dec 2002 | B1 |
| 6494875 | Mauch | Dec 2002 | B1 |
| 6494904 | Love | Dec 2002 | B1 |
| 6494907 | Bulver | Dec 2002 | B1 |
| 6494909 | Greenhalgh | Dec 2002 | B2 |
| 6497722 | Von Oepen et al. | Dec 2002 | B1 |
| 6497723 | Starck et al. | Dec 2002 | B1 |
| 6500202 | Shaolian et al. | Dec 2002 | B1 |
| 6500203 | Thompson et al. | Dec 2002 | B1 |
| 6500204 | Igaki | Dec 2002 | B1 |
| 6500532 | Ruefer et al. | Dec 2002 | B1 |
| 6503271 | Duerig et al. | Jan 2003 | B2 |
| 6506211 | Doran et al. | Jan 2003 | B1 |
| 6508833 | Pavcnik et al. | Jan 2003 | B2 |
| 6508834 | Pinchasik et al. | Jan 2003 | B1 |
| 6514281 | Blaeser et al. | Feb 2003 | B1 |
| 6517558 | Gittings et al. | Feb 2003 | B2 |
| 6517571 | Brauker et al. | Feb 2003 | B1 |
| 6517573 | Pollock et al. | Feb 2003 | B1 |
| 6517574 | Chuter | Feb 2003 | B1 |
| 6520983 | Colgan et al. | Feb 2003 | B1 |
| 6520984 | Garrison et al. | Feb 2003 | B1 |
| 6520986 | Martin et al. | Feb 2003 | B2 |
| 6524334 | Thompson | Feb 2003 | B1 |
| 6524335 | Hartley et al. | Feb 2003 | B1 |
| 6524336 | Papazolgou et al. | Feb 2003 | B1 |
| 6530765 | Zdrahala et al. | Mar 2003 | B1 |
| 6530947 | Euteneuer et al. | Mar 2003 | B1 |
| 6530950 | Alvarado et al. | Mar 2003 | B1 |
| 6533806 | Sullivan et al. | Mar 2003 | B1 |
| 6533807 | Wolinsky et al. | Mar 2003 | B2 |
| 6533808 | Thompson et al. | Mar 2003 | B1 |
| 6533811 | Ryan et al. | Mar 2003 | B1 |
| 6537202 | Frantzen | Mar 2003 | B1 |
| 6540778 | Quiachon et al. | Apr 2003 | B1 |
| 6540780 | Zilla et al. | Apr 2003 | B1 |
| 6547813 | Stiger et al. | Apr 2003 | B2 |
| 6547814 | Edwin et al. | Apr 2003 | B2 |
| 6547815 | Myers | Apr 2003 | B2 |
| 6547817 | Fischell et al. | Apr 2003 | B1 |
| 6548013 | Kadavy et al. | Apr 2003 | B2 |
| 6551350 | Thornton et al. | Apr 2003 | B1 |
| 6554857 | Zilla et al. | Apr 2003 | B1 |
| 6554858 | Dereume et al. | Apr 2003 | B2 |
| 6558414 | Layne | May 2003 | B2 |
| 6558415 | Thompson | May 2003 | B2 |
| 6562063 | Euteneuer et al. | May 2003 | B1 |
| 6565597 | Fearnot | May 2003 | B1 |
| 6569150 | Teague | May 2003 | B2 |
| 6569190 | Whalen, II et al. | May 2003 | B2 |
| 6569193 | Cox et al. | May 2003 | B1 |
| 6572649 | Berry et al. | Jun 2003 | B2 |
| 6575994 | Marin | Jun 2003 | B1 |
| 6576009 | Ryan et al. | Jun 2003 | B2 |
| 6579314 | Lombardi et al. | Jun 2003 | B1 |
| 6582458 | White et al. | Jun 2003 | B1 |
| 6589274 | Stiger et al. | Jul 2003 | B2 |
| 6589275 | Ivancev et al. | Jul 2003 | B1 |
| 6592614 | Lenker et al. | Jul 2003 | B2 |
| 6602269 | Wallace et al. | Aug 2003 | B2 |
| 6602280 | Chobotov | Aug 2003 | B2 |
| 6602283 | Doran et al. | Aug 2003 | B2 |
| 6605110 | Harrison | Aug 2003 | B2 |
| 6607551 | Sullivan et al. | Aug 2003 | B1 |
| 6613082 | Yang | Sep 2003 | B2 |
| 6613083 | Alt | Sep 2003 | B2 |
| 6613084 | Yang | Sep 2003 | B2 |
| 6620190 | Colone | Sep 2003 | B1 |
| 6626938 | Butaric et al. | Sep 2003 | B1 |
| 6635079 | Unsworth et al. | Oct 2003 | B2 |
| 6645240 | Yee | Nov 2003 | B2 |
| 6652554 | Wholey et al. | Nov 2003 | B1 |
| 6652570 | Smith et al. | Nov 2003 | B2 |
| 6652573 | Oepen | Nov 2003 | B2 |
| 6652575 | Wang | Nov 2003 | B2 |
| 6652580 | Chutter | Nov 2003 | B1 |
| 6656215 | Yanez et al. | Dec 2003 | B1 |
| 6656506 | Wu et al. | Dec 2003 | B1 |
| 6660030 | Shaolian et al. | Dec 2003 | B2 |
| 6663662 | Pacetti et al. | Dec 2003 | B2 |
| 6663663 | Kim et al. | Dec 2003 | B2 |
| 6663664 | Pacitti | Dec 2003 | B1 |
| 6663665 | Shaolian et al. | Dec 2003 | B2 |
| 6663667 | Dehdashtian et al. | Dec 2003 | B2 |
| 6669720 | Pierce | Dec 2003 | B1 |
| 6669723 | Killion et al. | Dec 2003 | B2 |
| 6669724 | Park et al. | Dec 2003 | B2 |
| 6673102 | Vonesh et al. | Jan 2004 | B1 |
| 6673103 | Golds et al. | Jan 2004 | B1 |
| 6673106 | Mitelberg et al. | Jan 2004 | B2 |
| 6673107 | Brandt et al. | Jan 2004 | B1 |
| 6676667 | Mareiro et al. | Jan 2004 | B2 |
| 6676695 | Solem | Jan 2004 | B2 |
| 6679911 | Burgermeister | Jan 2004 | B2 |
| 6685736 | White et al. | Feb 2004 | B1 |
| 6689158 | White et al. | Feb 2004 | B1 |
| 6689159 | Hartigan et al. | Feb 2004 | B2 |
| 6692523 | Holman et al. | Feb 2004 | B2 |
| 6694983 | Hall et al. | Feb 2004 | B2 |
| 6695833 | Frantzen | Feb 2004 | B1 |
| 6695875 | Stelter et al. | Feb 2004 | B2 |
| 6695877 | Brucker et al. | Feb 2004 | B2 |
| 6696666 | Merdan et al. | Feb 2004 | B2 |
| 6699274 | Stinson | Mar 2004 | B2 |
| 6699277 | Freidberg et al. | Mar 2004 | B1 |
| 6702847 | DiCarlo | Mar 2004 | B2 |
| 6702849 | Dutta et al. | Mar 2004 | B1 |
| 6706064 | Anson | Mar 2004 | B1 |
| 6709449 | Camrud et al. | Mar 2004 | B2 |
| 6709455 | Chouinard | Mar 2004 | B1 |
| 6712827 | Ellis et al. | Mar 2004 | B2 |
| 6716238 | Elliott | Apr 2004 | B2 |
| 6716239 | Sowinski | Apr 2004 | B2 |
| 6719783 | Lentz et al. | Apr 2004 | B2 |
| 6726712 | Raeder-Devens | Apr 2004 | B1 |
| 6730119 | Smalling | May 2004 | B1 |
| 6733521 | Chobotov et al. | May 2004 | B2 |
| 6736839 | Cummings | May 2004 | B2 |
| 6740111 | Lauterjung | May 2004 | B1 |
| 6740114 | Burgermeister | May 2004 | B2 |
| 6740115 | Lombardi | May 2004 | B2 |
| 6743210 | Hart et al. | Jun 2004 | B2 |
| 6743511 | Dittrich et al. | Jun 2004 | B2 |
| 6746890 | Gupta | Jun 2004 | B2 |
| 6752589 | Kocur et al. | Jun 2004 | B2 |
| 6755855 | Yurek et al. | Jun 2004 | B2 |
| 6758858 | McCrea et al. | Jul 2004 | B2 |
| 6761733 | Chobotov et al. | Jul 2004 | B2 |
| 6770086 | Girton et al. | Aug 2004 | B1 |
| 6770087 | Layne et al. | Aug 2004 | B2 |
| 6773453 | Ravenscroft | Aug 2004 | B2 |
| 6773457 | Gellman et al. | Aug 2004 | B2 |
| 6776604 | Chobotov et al. | Aug 2004 | B1 |
| 6776793 | Brown et al. | Aug 2004 | B2 |
| 6786920 | Shannon et al. | Aug 2004 | B2 |
| 6790227 | Burgermeister | Aug 2004 | B2 |
| 6790230 | Beyersdorf et al. | Aug 2004 | B2 |
| 6793672 | Khosravi et al. | Aug 2004 | B2 |
| 6796999 | Pinchasik | Aug 2004 | B2 |
| 6802849 | Siaeser et al. | Oct 2004 | B2 |
| 6802856 | Wilson | Oct 2004 | B2 |
| 6802859 | Pazienza et al. | Oct 2004 | B1 |
| 6814753 | Schmitt | Nov 2004 | B2 |
| 6818013 | Mitelberg et al. | Nov 2004 | B2 |
| 6821292 | Pazienza et al. | Nov 2004 | B2 |
| 6824558 | Parodi | Nov 2004 | B2 |
| 6827726 | Parodi | Dec 2004 | B2 |
| 6827731 | Annstrong et al. | Dec 2004 | B2 |
| 6827735 | Greenbeg | Dec 2004 | B2 |
| 6827737 | Hill et al. | Dec 2004 | B2 |
| 6833004 | Ishil et al. | Dec 2004 | B2 |
| 6841213 | Parsonage et al. | Jan 2005 | B2 |
| 6843802 | Villalobos et al. | Jan 2005 | B1 |
| 6849086 | Cragg | Feb 2005 | B2 |
| 6858035 | Whayne | Feb 2005 | B2 |
| 6860900 | Clerc et al. | Mar 2005 | B2 |
| 6863685 | Davila et al. | Mar 2005 | B2 |
| 6866805 | Hong et al. | Mar 2005 | B2 |
| 6869443 | Buscemi et al. | Mar 2005 | B2 |
| 6878160 | Gilligan et al. | Apr 2005 | B2 |
| 6878161 | Lenker | Apr 2005 | B2 |
| 6884260 | Kugler et al. | Apr 2005 | B2 |
| 6899728 | Philips et al. | May 2005 | B1 |
| 6918925 | Tehrani | Jul 2005 | B2 |
| 6918927 | Bates et al. | Jul 2005 | B2 |
| 6923827 | Campbell et al. | Aug 2005 | B2 |
| 6926732 | Derus et al. | Aug 2005 | B2 |
| 6929659 | Pinchuk | Aug 2005 | B2 |
| 6929709 | Smith | Aug 2005 | B2 |
| 6939370 | Hartley et al. | Sep 2005 | B2 |
| 6939374 | Banik et al. | Sep 2005 | B2 |
| 6942689 | Majercak | Sep 2005 | B2 |
| 6945989 | Rourke et al. | Sep 2005 | B1 |
| 6945992 | Goodson et al. | Sep 2005 | B2 |
| 6949120 | Kveen et al. | Sep 2005 | B2 |
| 6962602 | Vardi et al. | Nov 2005 | B2 |
| 6962603 | Brown | Nov 2005 | B1 |
| 6964677 | Osypka | Nov 2005 | B2 |
| 6974471 | Van Schie et al. | Dec 2005 | B2 |
| 6974472 | Hong et al. | Dec 2005 | B2 |
| 6981982 | Armstrong | Jan 2006 | B2 |
| 6989026 | Richter et al. | Jan 2006 | B2 |
| 6994722 | DiCarlo | Feb 2006 | B2 |
| 6997945 | Germain | Feb 2006 | B2 |
| 6998060 | Tomonto | Feb 2006 | B2 |
| 7001407 | Hansen et al. | Feb 2006 | B2 |
| 7001419 | DiCaprio et al. | Feb 2006 | B2 |
| 7001431 | Bao et al. | Feb 2006 | B2 |
| 7011673 | Fischell et al. | Apr 2006 | B2 |
| 7011674 | Brenneman | Apr 2006 | B2 |
| 7022132 | Kocur | Apr 2006 | B2 |
| 7022135 | Zilla et al. | Apr 2006 | B2 |
| 7033389 | Sherry | Apr 2006 | B2 |
| 7056325 | Makower | Jun 2006 | B1 |
| 7056336 | Armstrong et al. | Jun 2006 | B2 |
| 7056412 | Henderson | Jun 2006 | B2 |
| 7066951 | Chobotov | Jun 2006 | B2 |
| 7073504 | Callister et al. | Jul 2006 | B2 |
| 7081129 | Chobotov | Jul 2006 | B2 |
| 7081132 | Cook | Jul 2006 | B2 |
| 7083642 | Sirhan et al. | Aug 2006 | B2 |
| 7090693 | Chobotov et al. | Aug 2006 | B1 |
| 7094255 | Penn et al. | Aug 2006 | B2 |
| 7108715 | Brown et al. | Sep 2006 | B2 |
| 7115140 | Stoltze et al. | Oct 2006 | B2 |
| 7125464 | Chobotov et al. | Oct 2006 | B2 |
| 7128754 | Bolduc | Oct 2006 | B2 |
| 7128755 | Su et al. | Oct 2006 | B2 |
| 7147455 | Chobotov et al. | Dec 2006 | B2 |
| 7147660 | Chobotov et al. | Dec 2006 | B2 |
| 7147661 | Chobotov et al. | Dec 2006 | B2 |
| 7150758 | Kari et al. | Dec 2006 | B2 |
| 7160318 | Greenberg et al. | Jan 2007 | B2 |
| 7163553 | Limon | Jan 2007 | B2 |
| 7166125 | Baker et al. | Jan 2007 | B1 |
| 7175651 | Kerr | Feb 2007 | B2 |
| 7175652 | Cook et al. | Feb 2007 | B2 |
| 7189256 | Smith | Mar 2007 | B2 |
| 7192441 | Sherry | Mar 2007 | B2 |
| 7223280 | Anson et al. | Mar 2007 | B2 |
| 7226474 | Iancea et al. | Jun 2007 | B2 |
| 7229470 | Brian et al. | Jun 2007 | B2 |
| 7232459 | Greenberg | Jun 2007 | B2 |
| 7243408 | Vietmeier | Jul 2007 | B2 |
| 7244242 | Freyman | Jul 2007 | B2 |
| 7273494 | Rolando et al. | Sep 2007 | B2 |
| 7284399 | Sisco | Oct 2007 | B1 |
| 7294147 | Hartley | Nov 2007 | B2 |
| 7314484 | Deem et al. | Jan 2008 | B2 |
| 7318835 | Berra | Jan 2008 | B2 |
| 7338518 | Chobotov | Mar 2008 | B2 |
| 7351256 | Hojeibane et al. | Apr 2008 | B2 |
| 7425219 | Quadri | Sep 2008 | B2 |
| 7452374 | Hain et al. | Nov 2008 | B2 |
| 7465270 | Li | Dec 2008 | B2 |
| 7476245 | Abbate | Jan 2009 | B2 |
| 7485138 | Fearnot et al. | Feb 2009 | B2 |
| 7491230 | Holman et al. | Feb 2009 | B2 |
| 7491234 | Palasis et al. | Feb 2009 | B2 |
| 7500988 | Butaric et al. | Mar 2009 | B1 |
| 7510571 | Spiridiglozzi et al. | Mar 2009 | B2 |
| 7520890 | Phillips | Apr 2009 | B2 |
| 7520895 | Douglas et al. | Apr 2009 | B2 |
| 7530988 | Evans et al. | May 2009 | B2 |
| 7550004 | Bahaler et al. | Jun 2009 | B2 |
| 7550005 | Bates et al. | Jun 2009 | B2 |
| 7556645 | Lashinski et al. | Jul 2009 | B2 |
| 7591843 | Escano | Sep 2009 | B1 |
| 7597710 | Obermiller | Oct 2009 | B2 |
| 7604661 | Pavnick et al. | Oct 2009 | B2 |
| 7628803 | Pavnick et al. | Dec 2009 | B2 |
| 7766954 | Chobotov et al. | Aug 2010 | B2 |
| 7976575 | Hartley | Jul 2011 | B2 |
| 8025693 | Quigley | Sep 2011 | B2 |
| 8043356 | Kolbel et al. | Oct 2011 | B2 |
| 8066755 | Zacharias et al. | Nov 2011 | B2 |
| 8252036 | Cartledge et al. | Aug 2012 | B2 |
| 8535370 | Eckert et al. | Sep 2013 | B1 |
| 8784477 | Bregulla et al. | Jul 2014 | B2 |
| 9060852 | Grewe et al. | Jun 2015 | B2 |
| 11779479 | Aristizabal | Oct 2023 | B2 |
| 20010014794 | Moll | Aug 2001 | A1 |
| 20010019659 | Hirai | Sep 2001 | A1 |
| 20010029349 | Leschinsky | Oct 2001 | A1 |
| 20010039445 | Hall et al. | Nov 2001 | A1 |
| 20010041928 | Pavenik et al. | Nov 2001 | A1 |
| 20010044652 | Moore | Nov 2001 | A1 |
| 20010049534 | Lachat | Dec 2001 | A1 |
| 20020002400 | Drasler et al. | Jan 2002 | A1 |
| 20020007193 | Tanner et al. | Jan 2002 | A1 |
| 20020011684 | Bahar et al. | Jan 2002 | A1 |
| 20020016626 | DiMatteo et al. | Feb 2002 | A1 |
| 20020029051 | Callister et al. | Mar 2002 | A1 |
| 20020032408 | Parker et al. | Mar 2002 | A1 |
| 20020035395 | Sigimoto | Mar 2002 | A1 |
| 20020040236 | Lau et al. | Apr 2002 | A1 |
| 20020040237 | Lentz et al. | Apr 2002 | A1 |
| 20020042644 | Greenhalgh | Apr 2002 | A1 |
| 20020045931 | Sogard et al. | Apr 2002 | A1 |
| 20020045933 | Jang | Apr 2002 | A1 |
| 20020045934 | Jang | Apr 2002 | A1 |
| 20020045935 | Jang | Apr 2002 | A1 |
| 20020049487 | Lootz et al. | Apr 2002 | A1 |
| 20020049490 | Pollock et al. | Apr 2002 | A1 |
| 20020049493 | Jang | Apr 2002 | A1 |
| 20020052627 | Boylan et al. | May 2002 | A1 |
| 20020052644 | Shaolin et al. | May 2002 | A1 |
| 20020052649 | Greenhalgh | May 2002 | A1 |
| 20020055768 | Hess et al. | May 2002 | A1 |
| 20020055770 | Doran | May 2002 | A1 |
| 20020065552 | Jayaraman et al. | May 2002 | A1 |
| 20020072792 | Burgermeister et al. | Jun 2002 | A1 |
| 20020072793 | Rolando et al. | Jun 2002 | A1 |
| 20020076542 | Kramer et al. | Jun 2002 | A1 |
| 20020077692 | Besselink | Jun 2002 | A1 |
| 20020082680 | Stanley et al. | Jun 2002 | A1 |
| 20020082682 | Barclay et al. | Jun 2002 | A1 |
| 20020082685 | Sirhan et al. | Jun 2002 | A1 |
| 20020095208 | Gregorich et al. | Jul 2002 | A1 |
| 20020096252 | Lukic | Jul 2002 | A1 |
| 20020107561 | Pinheiro | Aug 2002 | A1 |
| 20020116050 | Kocur | Aug 2002 | A1 |
| 20020120321 | Gunderson et al. | Aug 2002 | A1 |
| 20020120327 | Cox | Aug 2002 | A1 |
| 20020123790 | White et al. | Sep 2002 | A1 |
| 20020123791 | Harrison | Sep 2002 | A1 |
| 20020123796 | Majercak et al. | Sep 2002 | A1 |
| 20020143387 | Soetikno et al. | Oct 2002 | A1 |
| 20020147492 | Shokoohi et al. | Oct 2002 | A1 |
| 20020151953 | Chobotov et al. | Oct 2002 | A1 |
| 20020151956 | Chobotov et al. | Oct 2002 | A1 |
| 20020156522 | Ryan et al. | Oct 2002 | A1 |
| 20020161376 | Barry et al. | Oct 2002 | A1 |
| 20020165603 | Thornton et al. | Nov 2002 | A1 |
| 20020169497 | Wholey et al. | Nov 2002 | A1 |
| 20020183826 | Dorn et al. | Dec 2002 | A1 |
| 20020183827 | Derus et al. | Dec 2002 | A1 |
| 20020188344 | Bolea et al. | Dec 2002 | A1 |
| 20020188346 | Healy et al. | Dec 2002 | A1 |
| 20020188347 | Mathis | Dec 2002 | A1 |
| 20020193867 | Gladdish, Jr. et al. | Dec 2002 | A1 |
| 20020193872 | Trout et al. | Dec 2002 | A1 |
| 20020193873 | Brucker et al. | Dec 2002 | A1 |
| 20020198585 | Wisselink | Dec 2002 | A1 |
| 20020198587 | Greenberg et al. | Dec 2002 | A1 |
| 20030004560 | Chobotov et al. | Jan 2003 | A1 |
| 20030004565 | Harnek et al. | Jan 2003 | A1 |
| 20030009212 | Kerr | Jan 2003 | A1 |
| 20030014075 | Rosenbluth et al. | Jan 2003 | A1 |
| 20030033001 | Igaki | Feb 2003 | A1 |
| 20030040803 | Rioux et al. | Feb 2003 | A1 |
| 20030050684 | Abrams et al. | Mar 2003 | A1 |
| 20030068296 | Ricci et al. | Apr 2003 | A1 |
| 20030074050 | Kerr | Apr 2003 | A1 |
| 20030083736 | Brown et al. | May 2003 | A1 |
| 20030088305 | Van Schie et al. | May 2003 | A1 |
| 20030097170 | Friedrich et al. | May 2003 | A1 |
| 20030116260 | Chobotov et al. | Jun 2003 | A1 |
| 20030120263 | Ouriel et al. | Jun 2003 | A1 |
| 20030120331 | Chobotov et al. | Jun 2003 | A1 |
| 20030125797 | Chobotov | Jul 2003 | A1 |
| 20030135256 | Gallagher et al. | Jul 2003 | A1 |
| 20030135261 | Kugler et al. | Jul 2003 | A1 |
| 20030176912 | Chuter et al. | Sep 2003 | A1 |
| 20030191518 | Spiridiglozzi et al. | Oct 2003 | A1 |
| 20030204236 | Letort | Oct 2003 | A1 |
| 20030204244 | Stiger | Oct 2003 | A1 |
| 20030212449 | Cox | Nov 2003 | A1 |
| 20030220683 | Minasian | Nov 2003 | A1 |
| 20030225453 | Murch | Dec 2003 | A1 |
| 20040024446 | Smith | Feb 2004 | A1 |
| 20040034407 | Sherry | Feb 2004 | A1 |
| 20040044395 | Nelson | Mar 2004 | A1 |
| 20040049212 | Whayne | Mar 2004 | A1 |
| 20040049264 | Sowinski et al. | Mar 2004 | A1 |
| 20040093055 | Bartorelli et al. | May 2004 | A1 |
| 20040093064 | Bosma | May 2004 | A1 |
| 20040093068 | Bergen et al. | May 2004 | A1 |
| 20040093078 | Moll et al. | May 2004 | A1 |
| 20040098091 | Erbel et al. | May 2004 | A1 |
| 20040098096 | Eton | May 2004 | A1 |
| 20040106974 | Greenberg et al. | Jun 2004 | A1 |
| 20040116997 | Taylor et al. | Jun 2004 | A1 |
| 20040138734 | Chobotov et al. | Jul 2004 | A1 |
| 20040148008 | Goodson et al. | Jul 2004 | A1 |
| 20040162607 | Masroor | Aug 2004 | A1 |
| 20040167614 | Anson | Aug 2004 | A1 |
| 20040167619 | Case et al. | Aug 2004 | A1 |
| 20040176836 | Chobotov | Sep 2004 | A1 |
| 20040186558 | Pavnick et al. | Sep 2004 | A1 |
| 20040210304 | Seguin et al. | Oct 2004 | A1 |
| 20040215213 | Dolan | Oct 2004 | A1 |
| 20040220655 | Swanson et al. | Nov 2004 | A1 |
| 20040220664 | Chobotov | Nov 2004 | A1 |
| 20040254625 | Stephens | Dec 2004 | A1 |
| 20050033406 | Barnhart et al. | Feb 2005 | A1 |
| 20050049674 | Berra et al. | Mar 2005 | A1 |
| 20050049691 | Mercile et al. | Mar 2005 | A1 |
| 20050058920 | Tokarski et al. | Mar 2005 | A1 |
| 20050075715 | Borges et al. | Apr 2005 | A1 |
| 20050090804 | Chobotov et al. | Apr 2005 | A1 |
| 20050090901 | Studer | Apr 2005 | A1 |
| 20050154443 | Linder et al. | Jul 2005 | A1 |
| 20050158272 | Whirley et al. | Jul 2005 | A1 |
| 20050171593 | Whirley et al. | Aug 2005 | A1 |
| 20050177222 | Mead | Aug 2005 | A1 |
| 20050178732 | Chobotov et al. | Aug 2005 | A1 |
| 20050222669 | Purdy | Oct 2005 | A1 |
| 20050228484 | Stephens et al. | Oct 2005 | A1 |
| 20060009833 | Chobotov et al. | Jan 2006 | A1 |
| 20060020319 | Kim | Jan 2006 | A1 |
| 20060030921 | Berra | Feb 2006 | A1 |
| 20060079952 | Kaplan et al. | Apr 2006 | A1 |
| 20060136047 | Obermiller et al. | Jun 2006 | A1 |
| 20060149364 | Walak et al. | Jul 2006 | A1 |
| 20060161244 | Seguin | Jul 2006 | A1 |
| 20060161245 | Rakos et al. | Jul 2006 | A1 |
| 20060178732 | Chobotov et al. | Aug 2006 | A1 |
| 20060186143 | Argentine | Aug 2006 | A1 |
| 20060212112 | Evans et al. | Sep 2006 | A1 |
| 20060224232 | Chobotov | Oct 2006 | A1 |
| 20060233990 | Humphrey et al. | Oct 2006 | A1 |
| 20060233991 | Humphrey et al. | Oct 2006 | A1 |
| 20060287713 | Douglas et al. | Dec 2006 | A1 |
| 20060292206 | Kim et al. | Dec 2006 | A1 |
| 20070012396 | Chobotov et al. | Jan 2007 | A1 |
| 20070016281 | Melsheimer | Jan 2007 | A1 |
| 20070055347 | Arbeferize | Mar 2007 | A1 |
| 20070100427 | Perouse | May 2007 | A1 |
| 20070112413 | Smith | May 2007 | A1 |
| 20070162106 | Evans et al. | Jul 2007 | A1 |
| 20070167901 | Herrig et al. | Jul 2007 | A1 |
| 20070203571 | Kaplan et al. | Aug 2007 | A1 |
| 20070219627 | Chu et al. | Sep 2007 | A1 |
| 20070239273 | Allen | Oct 2007 | A1 |
| 20070244539 | Lentz et al. | Oct 2007 | A1 |
| 20070276477 | Lee et al. | Nov 2007 | A1 |
| 20070282369 | Gilson et al. | Dec 2007 | A1 |
| 20080015687 | Lashinski et al. | Jan 2008 | A1 |
| 20080027529 | Hartley et al. | Jan 2008 | A1 |
| 20080039926 | Majercak et al. | Feb 2008 | A1 |
| 20080051705 | Von Oepen et al. | Feb 2008 | A1 |
| 20080114441 | Rust | May 2008 | A1 |
| 20080114442 | Mitchell et al. | May 2008 | A1 |
| 20080114443 | Mitchell | May 2008 | A1 |
| 20080132995 | Burgermeister et al. | Jun 2008 | A1 |
| 20080172119 | Yamasaki et al. | Jul 2008 | A1 |
| 20080115678 | Clarke et al. | Sep 2008 | A1 |
| 20080228255 | Rust | Sep 2008 | A1 |
| 20080255652 | Thomas et al. | Oct 2008 | A1 |
| 20090005854 | Huang et al. | Jan 2009 | A1 |
| 20090036971 | Humphrey et al. | Feb 2009 | A1 |
| 20090042796 | Wallach et al. | Feb 2009 | A1 |
| 20090082841 | Zacharias et al. | Mar 2009 | A1 |
| 20090082842 | Glynn | Mar 2009 | A1 |
| 20090082845 | Chobotov et al. | Mar 2009 | A1 |
| 20090082846 | Chobotov et al. | Mar 2009 | A1 |
| 20090082847 | Zacharias et al. | Mar 2009 | A1 |
| 20090092844 | Zacharias et al. | Mar 2009 | A1 |
| 20090099649 | Chobotov et al. | Apr 2009 | A1 |
| 20090125095 | Bui et al. | May 2009 | A1 |
| 20090132020 | Watson | May 2009 | A1 |
| 20090132026 | Martin et al. | May 2009 | A1 |
| 20090171431 | Swanson et al. | Jul 2009 | A1 |
| 20090182406 | Blaeser et al. | Jul 2009 | A1 |
| 20090198267 | Evans et al. | Aug 2009 | A1 |
| 20090287145 | Cragg | Nov 2009 | A1 |
| 20100114290 | Rassmussen et al. | May 2010 | A1 |
| 20100161028 | Chuter et al. | Jun 2010 | A1 |
| 20100211052 | Brown et al. | Aug 2010 | A1 |
| 20100249908 | Chau et al. | Sep 2010 | A1 |
| 20100286760 | Beach et al. | Nov 2010 | A1 |
| 20100305686 | Cragg | Dec 2010 | A1 |
| 20100331958 | Chobotov et al. | Dec 2010 | A1 |
| 20110130819 | Cragg | Jun 2011 | A1 |
| 20110130820 | Cragg | Jun 2011 | A1 |
| 20110130824 | Cragg | Jun 2011 | A1 |
| 20110130825 | Cragg | Jun 2011 | A1 |
| 20110130826 | Cragg | Jun 2011 | A1 |
| 20110218609 | Chobotov | Sep 2011 | A1 |
| 20110238160 | Molony | Sep 2011 | A1 |
| 20110295356 | Abunassar | Dec 2011 | A1 |
| 20120016457 | Chobotov et al. | Jan 2012 | A1 |
| 20120041543 | Huang et al. | Feb 2012 | A1 |
| 20120130469 | Cragg | May 2012 | A1 |
| 20120191174 | Vinluan et al. | Jul 2012 | A1 |
| 20130090715 | Chobotov et al. | Apr 2013 | A1 |
| 20130268044 | Parsons et al. | Oct 2013 | A1 |
| 20130268048 | Watson et al. | Oct 2013 | A1 |
| Number | Date | Country |
|---|---|---|
| 2438087 | Mar 2001 | CA |
| 19624642 | Jan 1998 | DE |
| 0646365 | Apr 1995 | EP |
| 0714641 | Jun 1996 | EP |
| 0775472 | May 1997 | EP |
| 0792627 | Sep 1997 | EP |
| 0808613 | Nov 1997 | EP |
| 0819411 | Jan 1998 | EP |
| 0878175 | Nov 1998 | EP |
| 0943302 | Sep 1999 | EP |
| 0997115 | May 2000 | EP |
| 0480667 | Apr 2001 | EP |
| 1093772 | Apr 2001 | EP |
| 1138280 | Oct 2001 | EP |
| A 1138280 | Oct 2001 | EP |
| 0808140 | Dec 2001 | EP |
| 1163991 | Dec 2001 | EP |
| 1212991 | Jun 2002 | EP |
| 1266636 | Dec 2002 | EP |
| 1380270 | Jan 2004 | EP |
| 1415617 | Apr 2004 | EP |
| 1 611 867 | Jan 2006 | EP |
| 1683541 | Jul 2006 | EP |
| 2 158 880 | Mar 2010 | EP |
| 1360967 | Nov 2013 | EP |
| 49 042773 | Apr 1974 | JP |
| 3109404 | May 1991 | JP |
| 5161665 | Jun 1993 | JP |
| 6100054 | Apr 1994 | JP |
| 09117511 | May 1997 | JP |
| 18-126862 | Jun 2006 | JP |
| 18-136382 | Jun 2006 | JP |
| 1768154 | Oct 1992 | RU |
| 1812980 | Apr 1993 | RU |
| 2029527 | Feb 1995 | RU |
| 1217402 | Mar 1986 | SU |
| 1237201 | Jun 1986 | SU |
| 1237202 | Jun 1986 | SU |
| 1273077 | Nov 1986 | SU |
| 1342511 | Oct 1987 | SU |
| 1389778 | Apr 1988 | SU |
| 1457921 | Feb 1989 | SU |
| 1482714 | May 1989 | SU |
| 1560134 | Apr 1990 | SU |
| 1586718 | Aug 1990 | SU |
| 1650127 | May 1991 | SU |
| 1732964 | May 1992 | SU |
| WO 91000792 | Jan 1991 | WO |
| WO 92022604 | Dec 1992 | WO |
| WO 93013824 | Jul 1993 | WO |
| WO 93019804 | Oct 1993 | WO |
| WO 94003127 | Feb 1994 | WO |
| WO 9501761 | Jan 1995 | WO |
| WO 95003754 | Feb 1995 | WO |
| WO 95005132 | Feb 1995 | WO |
| WO 95009586 | Apr 1995 | WO |
| WO 96014095 | May 1996 | WO |
| WO 9614808 | May 1996 | WO |
| WO 9703624 | Feb 1997 | WO |
| WO 97007751 | Mar 1997 | WO |
| WO 9729716 | Aug 1997 | WO |
| WO 97048350 | Dec 1997 | WO |
| WO 98006355 | Feb 1998 | WO |
| WO 98038947 | Sep 1998 | WO |
| WO 98041167 | Sep 1998 | WO |
| WO 98044870 | Oct 1998 | WO |
| WO 98044873 | Oct 1998 | WO |
| WO 99000073 | Jan 1999 | WO |
| WO 99026559 | Jun 1999 | WO |
| WO 99038455 | Aug 1999 | WO |
| WO 99043378 | Sep 1999 | WO |
| WO 99043379 | Sep 1999 | WO |
| WO 00010487 | Mar 2000 | WO |
| WO 0013613 | Mar 2000 | WO |
| WO 00042947 | Jul 2000 | WO |
| WO 00042948 | Jul 2000 | WO |
| WO 00044808 | Aug 2000 | WO |
| WO 00051522 | Sep 2000 | WO |
| WO 0067675 | Nov 2000 | WO |
| WO 00071179 | Nov 2000 | WO |
| WO 0105331 | Jan 2001 | WO |
| WO 01008599 | Feb 2001 | WO |
| WO 01015633 | Mar 2001 | WO |
| WO 01021108 | Mar 2001 | WO |
| WO 01030270 | May 2001 | WO |
| WO 01041675 | Jun 2001 | WO |
| WO 01056500 | Aug 2001 | WO |
| WO 01056504 | Aug 2001 | WO |
| WO 01058384 | Aug 2001 | WO |
| WO 0158387 | Aug 2001 | WO |
| WO 01066037 | Sep 2001 | WO |
| WO 01067993 | Sep 2001 | WO |
| WO 01074270 | Oct 2001 | WO |
| WO 01076509 | Oct 2001 | WO |
| WO 01082836 | Nov 2001 | WO |
| WO 02036332 | May 2002 | WO |
| WO 02041804 | May 2002 | WO |
| WO 02078569 | Oct 2002 | WO |
| WO 02083038 | Oct 2002 | WO |
| WO 02100454 | Dec 2002 | WO |
| WO 03022180 | Mar 2003 | WO |
| WO 03053287 | Jul 2003 | WO |
| WO 03053288 | Jul 2003 | WO |
| WO 03094795 | Nov 2003 | WO |
| WO 03094799 | Nov 2003 | WO |
| WO 04002370 | Jan 2004 | WO |
| WO 04002371 | Jan 2004 | WO |
| WO 04017866 | Mar 2004 | WO |
| WO 04078065 | Sep 2004 | WO |
| WO 05037076 | Apr 2005 | WO |
| WO 05086942 | Sep 2005 | WO |
| WO 06107562 | Oct 2006 | WO |
| WO 09042796 | Apr 2009 | WO |
| WO 09086200 | Jul 2009 | WO |
| WO 11100367 | Aug 2011 | WO |
| WO 12068175 | Aug 2012 | WO |
| Entry |
|---|
| US 6,413,270 B1, 07/2002, Thornton et al. (withdrawn) |
| Office Action dated Mar. 28, 2014 in U.S. Appl. No. 13/297,219, filed Nov. 15, 2011 and published as: US2012/0191174 on: Jul. 26, 2012. |
| Office Action dated May 22, 2014 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action dated Jun. 4, 2014 in U.S. Appl. No. 13/799,207, filed Mar. 13, 2013 and published as: US2013/0268044 on: Oct. 10, 2013. |
| Office Action dated Dec. 7, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action Response dated Oct. 21, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action dated Nov. 28, 2011 in U.S. Appl. No. 12/747,499, filed Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
| Final Office Action dated Jan. 19, 2011, from U.S. Appl. No. 12/245,620. |
| Final Office Action dated Mar. 13, 2015, from U.S. Appl. No. 12/245,620. |
| Non-final Office Action dated Jun. 19, 2014, from U.S. Appl. No. 12/245,620. |
| Non-final Office Action dated May 14, 2010, from U.S. Appl. No. 12/245,620. |
| Non-Final Office Action dated Sep. 18, 2019, from U.S. Appl. No. 16/231,219. |
| Notice of Allowance dated Aug. 16, 2018, from U.S. Appl. No. 12/245,620. |
| Notice of Allowance dated Feb. 12, 2020, from U.S. Appl. No. 16/231,219. |
| Extended European Search Report dated Jan. 27, 2015 in European Application No. EP 11841183.4 filed: Nov. 15, 2011. |
| Supplemental European Search Report dated Feb. 13, 2015 in European Application No. EP 11841183.4 filed: Nov. 15, 2011. |
| Extended European Search Report dated Oct. 8, 2015 in European Application No. EP 13771941.5 filed: Apr. 1, 2013. |
| Extended European Search Report dated Nov. 9, 2015 in European Application No. EP 13772199.9 filed: Mar. 29, 2013. |
| International Search Report and Written Opinion dated Feb. 2, 2016 in International Patent Application No. PCT/US2015/057016 filed: Oct. 22, 2015 and published as: WO/2016/065208 on: Apr. 28, 2016. |
| Notice of Allowance dated Nov. 7, 2014 in U.S. Appl. No. 13/799,207, filed Mar. 13, 2013 and published as: US2013/0268044 on: Oct. 10, 2013. |
| Office Action Response dated Sep. 25, 2014 in U.S. Appl. No. 13/799,207, filed Mar. 13, 2013 and published as: US2013/0268044 on: Oct. 10, 2013. |
| Office Action Response dated Aug. 18, 2016 in U.S. Appl. No. 14/615,337, filed Feb. 5, 2015 and published as: 2015-0157479 on Jun. 11, 2015. |
| Office Action dated Apr. 22, 2016 in U.S. Appl. No. 14/615,337, filed Feb. 5, 2015 and published as: 2015-0157479 on Jun. 11, 2015. |
| Office Action Response dated Feb. 29, 2016 in U.S. Appl. No. 14/615,337, filed Feb. 5, 2015 and published as: 2015-0157479 on Jun. 11, 2015. |
| Office Action dated Sep. 28, 2015 in U.S. Appl. No. 14/615,337, filed Feb. 5, 2015 and published as: 2015-0157479 on Jun. 11, 2015. |
| Office Action dated Oct. 1, 2014 in U.S. Appl. No. 13/297,219, filed Nov. 15, 2011 and published as: US2012/0191174 on: Jul. 26, 2012. |
| Office Action dated Dec. 31, 2014 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action Response dated Sep. 11, 2014 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| The AneuRx® Stent Graft System Treatment for AAA brochure, “An Innovative Modular Approach for the Treatment of Abdominal Aortic Aneurysms (AAA),” Medtronic AVE, Inc. 1999. |
| The AneuRx® Stent Graft Treatment for TAA brochure, “An Endoluminal Solution for the Treatment of Descending Thoracic Aortic Aneurysms,” Medtronic, Inc. 1999. |
| Blum et al. “Abdominal aortic aneurysms: preliminary technical and clinical results with transfemoral placement of endovascular self-expanding stent-grafts” Radiology 198(1):25-31 (1996). ;198(1):25-31 (1996). |
| Blum et al. “Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms” Engl J Med 336(1):13-20 (1997). ;336(1):13-20 (1997). |
| Campbell et al., “Balloon-Artery Interactions During Stent Placement: A Finite Element Analysis Approach to Pressure, Compliance, and Stent Design as Contributors to Vascular Injury”; 1999; American Heart Association; pp. 378-383. |
| Canero et al., “Optimal stent implantation: three-dimensional evaluation of the mutual position of stent and vessel via intracoronary echocardiography,” Computers in Cardiology, 261-264 (Sep. 1999). |
| Cooley, Denton A., Surgical Treatment of Aortic Aneurysms (Book), W.B. Saunders Company, West Washington Square, PA (1986). |
| Donayre, et al., “Fillable endovascular aneurysm repair”, Endovascular Today, p. 64-66, Jan. 2009. |
| Dumoulin C. et al., “Mechanical behavior modeling of balloon expandable stents.” Journal of Biomechanics, vol. 33, No. 11, pp. 1461-1470 (available online: Sep. 8, 2000). |
| Elger et al. “The Influence of Shape on the Stresses in Model Abdominal Aortic Aneurysms,” Transactions of the ASME 326:326-32 (1996). |
| Ernst “Current therapy for infrarenal aortic aneurysms” N Engl J Med 336(1):58-60 (1997). |
| Haimovitch, L. and Patierson, N., “Robust growth is forecast for endovascular repair of AAAs,” The BBI Newsletter, vol. 26, No. 5, pp. 113-144, (May 2003). |
| How et al. “Mechanical Properties of Arteries and Arterial Grafts,” Chapter 1 of Cardiovascular Biomaterials Hasting, G.W. (ed.) London; New York: Springer-Verlag, 1992 pp. 1-35. |
| International Search Report and Written Opinion dated May 28, 2009 for International Application No. PCT/US2008/087831 filed on Dec. 19, 2008 and published as WO/2009/086200 on Jul. 9, 2009. |
| Lakshmiraghavan, M, Mechanical Wall Stress in Abdominal Aortic Aneurysm: Towards the Development of a Clinical Tool to Predict Aneurysm Rupture. Submitted to the University of Pittsburgh, vol. 59/09-B of Dissertation Abstracts International p. 4948. 285 pages (1998). |
| Mandai, S. et al. (1992). “Direct Thrombosis of Aneurysms with Cellulose Acetate Polymer. Part I: Results of Thrombosis in Experimental Aneurysms,” J. Neurosurgery 77:497-500. |
| Mirich et al., “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study”, Radiology, 170/3:1033-1037 (1989); 1033-1037 (1989). |
| Moore et al. “Transfemoral endovascular repair of abdominal aortic aneurysm: results of the North American EVT phase 1 trial” J Vasc Surg 23(4):543-553 (1996). ;23(4):543-553 (1996). |
| Mower et al. “Stress Distributions in Vascular Aneurysms: Factors Affecting Risk of Aneurysm Rupture,” J. Surgical Research 55:151-61 (1993). |
| Office Action dated Oct. 1, 2009 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| Parodi “Endovascular repair of abdominal aortic aneurysms and other arterial lesions” J Vasc Surg 21(4):549-557 (1995).;21(4):549-557 (1995). |
| Parodi et al., “Transfemoral intraluminal graft implantation for abdominal aortic aneurysms,” Ann. Vasc. Surg., 5(6):491-499 (1991). |
| Perry, M. D. and Chang, R. T., “Finite Element Analysis of Ni—Ti Alloy Stent Deployment,” Proceedings of the Second International Conference on SMST, Asilomar Conference Center, Pacific Grove CA. USA (1997). |
| Rogers et al., “Balloon-Artery Interactions During Stent Placement: A finite element analysis approach to pressure, compliance and stent design as contributors to vascular injury”, 1999 American Heart Association pp. 378-383. |
| Stern et al., “Interactive Definition of Endoluminal Aortic Stent Size and Morphology Based on Virtual Angioscopic Rendering of 3D Magnetic Resonance Angiography (MRA),” Cars. Computer Assisted Radiology and Surgery, Proceedings of the International Symposium on Computer Assisted Radiology and Surgery:176-180 (Jun. 1999). |
| Uflacker, R. and Robinson, J., “Endovascular treatment of abdominal aortic aneurysms: a review,” Eur. Radial., 11:739-753 (2001). |
| Verhagen “Latest AAA Innovations: The Endurant Stent Graft System”, Veith Symposium Nov. 17, 2007. |
| Verhagen, Hence J.M. “Endurant Medtronic Endograft for EVAR: advantages & early experience”, Slides from Veith Symposium Presentation Nov. 22, 2008. |
| Vos, A.F.W. et al., “Endovascular Grafting of Complex Aortic Aneurysms with a modular site Branch Stent Graft System in a Porcine Model”, Eur J Vasc Endovasc Surg, May 2004 vol. 27 492-497. |
| Volodos, N.L. et a1. (1987). “New Balloon Catheter For Dilating Arteries and Installing Prosthesis During Distal Endoprosthetics With Self-Fixing Synthetic Prosthesis,” Thesis of VIII Symposium (Oct. 8-10, 1987), Abstract Only in English, four pages. |
| Volodos, N.L. et al. (1986) “Self-Fixing Synthetic Prostheisis for Endoprosthesis of Vessels,” Vestnik Khigurgii pp. 123-124, Abstract Only in English. |
| Volodos, N.L. et al. (1989). “Clinical Experience In Use of Self-Fixing Synthetic Prosthesis For Distal and Intraoperative Endoprosthestics of Aora and Iliac Arteries,” Theses of Ixth All-Union Symposium (Oct. 2-3, 1989), Abstract only in English, four pages. |
| Web page, “Drug Eluting Stents—Why Use Drug Eluting Stents?” Polymer Coatings Division; at: URL http://www.lombardmedical.co.uk/lombard/pcde.why.html; Lombard Medical; printed Feb. 1, 2005. |
| Whitcher, “Simulation of in vivo loading conditions of nitinol vascular stent structures”, 1997, Elsevier Science Ltd., pp. 1005-1011. |
| Whitcher, F., “A Finite Element Treatment of the In-Vivo Loading Conditions of NITI AD Vascular Stent and Graft Structures,” Proceedings of the Second International Conference on SMST, Asilomar Conference Center, Pacific Grove. CA, USA (1997). |
| Wisselink, W. et al. (2001). “Clipping of Inferior Mesenteric and Lumbar Arteries via Retroperitoneal Laparo-Endoscopic Approach as a Treatment of Persistent Endoleak” Chapter 18 In Endoleaks and Endotension, Veith, F.J. et al. eds. Marcel Dekker, Inc. pp. 211-220. |
| Extended European Search Report dated Dec. 16, 2009 in European Application No. 09175398.8 filed: Oct. 15, 2004 and published as: EP 2145607 on Jan. 20, 2010. |
| International Preliminary Report on Patentability dated Apr. 15, 2010 for International Application No. PCT/US2008/078846 filed on Oct. 3, 2008 and published as WO/2009/046372 on Apr. 9, 2009. |
| International Search Report and Written Opinion dated Jul. 30, 2009 for International Application No. PCT/US2008/078846 filed on Oct. 3, 2008 and published as WO/2009/046372 on Apr. 9, 2009. |
| International Preliminary Report on Patentability dated Apr. 8, 2010 for International Application No. PCT/US2008/077714 filed on Sep. 25, 2008 and published as WO/2009/042789 on Apr. 2, 2009. |
| International Search Report and Written Opinion dated May 1, 2009 for International Application No. PCT/US2008/077714 filed on Sep. 25, 2008 and published as WO/2009/042789 on Apr. 2, 2009. |
| International Preliminary Report on Patentability dated May 27, 2010 for International Application No. PCT/US2008/083451 filed on Nov. 13, 2008 and published as WO/2009/064923 on May 22, 2009. |
| International Search Report and Written Opinion dated Jun. 30, 2009 for International Application No. PCT/US2008/083451 filed on Nov. 13, 2008 and published as WO/2009/064923 on May 22, 2009. |
| International Search Report and Written Opinion dated Mar. 26, 2009 for International Application No. PCT/US2008/077727 filed on Sep. 25, 2008 and published as WO2009/042796 on Apr. 2, 2009. |
| International Preliminary Report on Patentability dated Apr. 8, 2010 for International Application No. PCT/US2008/077727 filed on Sep. 25, 2008 and published as WO2009/042796 on Apr. 2, 2009. |
| Office Action dated Jan. 14, 2010 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action Response dated Jun. 14, 2010 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action dated Apr. 1, 2010 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action Response dated Jan. 4, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| Office Action dated Apr. 14, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| Final Office Action dated Dec. 1, 2016 in U.S. Appl. No. 14/615,337, filed Feb. 5, 2015 and published as: 2015-0157479 on Jun. 11, 2015. |
| Extended European Search Report dated Apr. 5, 2013 in European Application No. EP 08849544 filed: Nov. 13, 2008. |
| Invitation to Pay Additional Fees and Partial Search Report dated Apr. 25, 2013 for International Application No. PCT/US2011/060873 filed on Nov. 15, 2011 and published as WO/2012/068175 on Aug. 2, 2012. |
| International Search Report and Written Opinion dated Jun. 12, 2012 for International Application No. PCT/US2011/060873 filed on Nov. 15, 2011 and published as WO/2012/068175 on Aug. 2, 2012. |
| Non-Final Office Action dated May 19, 2017 in U.S. Appl. No. 14/615,337, filed Feb. 5, 2015 and published as: 2015-0157479 on Jun. 11, 2015. |
| Request For Continued Examination dated Apr. 3, 2017 in U.S. Appl. No. 14/615,337, filed Feb. 5, 2015 and published as: 2015-0157479 on Jun. 11, 2015. |
| Extended European Search Report dated Dec. 17, 2012 in European Application No. EP 08835032 filed: Oct. 3, 2008. |
| Office Action Response dated Oct. 24, 2012 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action dated Apr. 27, 2012 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action dated Jun. 7, 2012 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action dated Apr. 11, 2012 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action dated Jan. 30, 2013 in U.S. Appl. No. 12/747,499, filed Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
| Office Action Response dated Dec. 11, 2012 in U.S. Appl. No. 12/747,499, filed Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
| Office Action dated Jun. 18, 2012 in U.S. Appl. No. 12/747,499, filed Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
| Office Action Response dated May 17, 2012 in U.S. Appl. No. 12/747,499, filed Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
| Office Action dated Mar. 13, 2012 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| Extended European Search Report dated Jul. 27, 2010 in European Application No. 10005904.7 filed: Apr. 11, 2002 and published as: EP 2221023 on Aug. 25, 2010. |
| Office Action dated Aug. 26, 2010 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action Response dated Sep. 1, 2010 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action dated Oct. 6, 2010 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action dated Nov. 23, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| International Search Report and Written Opinion dated Jul. 18, 2013 for International Application No. PCT/US2013/034654, filed on Mar. 29, 2013 and published as WO 2013/151896 on Oct. 10, 2013. |
| International Search Report and Written Opinion dated Jul. 18, 2013 for International Application No. PCT/US2013/034787, filed on Apr. 1, 2013 and published as WO 2013/151924 on Oct. 10, 2013. |
| Office Action dated Sep. 18, 2013 in U.S. Appl. No. 11/861,828, filed Sep. 26, 2007 and published as 2009-0082846 on Mar. 26, 2009. |
| Office Action dated Jul. 13, 2017 in U.S. Appl. No. 14/631,818, filed Feb. 25, 2015 and published as: US-2015/0164667 on: Jun. 18, 2015. |
| International Preliminary Report on Patentability mailed on Jul. 1, 2010 for International Application No. PCT/US2008/087831 filed on Dec. 19, 2008 and published as WO/2009/086200 on Jul. 9, 2009. |
| International Search Report and Written Opinion mailed on May 28, 2009 for International Application No. PCT/US2008/087831 filed on Dec. 19, 2008 and published as WO/2009/086200 on Jul. 9, 2009. |
| Office Action Response mailed Jul. 15, 2011 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action mailed: Mar. 15, 2011 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action Response mailed Jan. 26, 2011 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
| Office Action mailed: Apr. 26, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action Response mailed Apr. 5, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
| Office Action mailed: Jun. 21, 2011 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| Office Action Response mailed: May 23, 2011 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| Office Action Response mailed on Oct. 12, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
| Number | Date | Country | |
|---|---|---|---|
| 20200375725 A1 | Dec 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60977617 | Oct 2007 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16231219 | Dec 2018 | US |
| Child | 16902155 | US | |
| Parent | 12245620 | Oct 2008 | US |
| Child | 16231219 | US |
